{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"lanreotide","name":"Lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":74,"objects":{"clinicaltrials-gov-nct00565097-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00565097-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct00565097-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00565097-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct00565097-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct00565097-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct00565097-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2009-02-17","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00565097","sourceIds":["ctg-observation-nct00565097-2009-02-17-7507d373d98f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00565097 at 2026-07-30T22:26:45.013Z. Its registry update date was 2009-02-17, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct00565097-2009-02-17-7507d373d98f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00565097 at 2026-07-30T22:26:45.013Z. Its registry update date was 2009-02-17, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct00565097-2009-02-17-7507d373d98f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00565097-2009-02-17-7507d373d98f"]}],"sources":[{"id":"ctg-observation-nct00565097-2009-02-17-7507d373d98f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00565097 · retained source version 2009-02-17:7507d373d98fb7650bba38798eb4db96adc34f2431778105b352cc0e291ee934","url":"https://clinicaltrials.gov/study/NCT00565097"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8cb77d92232e325c8edf8b89c3c31fd5f47fb63d3f1f4ea359ced8768f90345f","tierARecordSha256":"2c61eac5358200af1f8dbfe342677639b236916e3d708b6a9075f280ac47939e"},"integrity":{"algorithm":"sha256","contentSha256":"6cae0731c63d1b002e905d4498761bb34dacadd4d9b3db52aa5c4a27eefb8028"}},"clinicaltrials-gov-nct00774930-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00774930-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct00774930-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00774930-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct00774930-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct00774930-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct00774930-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2022-10-14","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00774930","sourceIds":["ctg-observation-nct00774930-2022-10-14-2552601a3948"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00774930 at 2026-07-30T19:34:18.792Z. Its registry update date was 2022-10-14, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct00774930-2022-10-14-2552601a3948"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00774930 at 2026-07-30T19:34:18.792Z. Its registry update date was 2022-10-14, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct00774930-2022-10-14-2552601a3948"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00774930-2022-10-14-2552601a3948"]}],"sources":[{"id":"ctg-observation-nct00774930-2022-10-14-2552601a3948","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00774930 · retained source version 2022-10-14:2552601a394812b0cf57f21a1e1ce77b6c64078dcac3c0d1afa181d9232d57ac","url":"https://clinicaltrials.gov/study/NCT00774930"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"74ebe6ea5b5693bec45321b5c6c538cc143fa7d08034fbe0b1fca2c15572c9ed","tierARecordSha256":"d8784798e40adca3fea8348921de7b9e62e264a54b44952f4154a436a444165f"},"integrity":{"algorithm":"sha256","contentSha256":"f1929d5ac263f43000adb02444a2decda2f1721f04d1d09b69146cf7572153e4"}},"clinicaltrials-gov-nct01354405-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01354405-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct01354405-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01354405-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct01354405-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct01354405-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct01354405-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2014-07-09","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01354405","sourceIds":["ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01354405 at 2026-07-30T21:54:46.540Z. Its registry update date was 2014-07-09, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01354405 at 2026-07-30T21:54:46.540Z. Its registry update date was 2014-07-09, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2"]}],"sources":[{"id":"ctg-observation-nct01354405-2014-07-09-73f5a87d9ec2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01354405 · retained source version 2014-07-09:73f5a87d9ec20517cd117812ffdecdcabf42001280f69b3b2427f9eb064504d1","url":"https://clinicaltrials.gov/study/NCT01354405"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e43090a81b2b4759c3890b34eae344b941238b1f06b4aa24ead43f56a4d944f2","tierARecordSha256":"e201147972532d9a8b03209fde1d0af55db57e962fd699a21b94f63772e5e89f"},"integrity":{"algorithm":"sha256","contentSha256":"f822f2fadc596ecff2e58b83ac10c385a758ef0b5e882ad0cc8bdfb7fd6306d0"}},"clinicaltrials-gov-nct02075606-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02075606-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct02075606-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02075606-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct02075606-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct02075606-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct02075606-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2019-06-07","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02075606","sourceIds":["ctg-observation-nct02075606-2019-06-07-2b3824e73b3a"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02075606 at 2026-07-30T20:50:35.870Z. Its registry update date was 2019-06-07, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02075606-2019-06-07-2b3824e73b3a"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02075606 at 2026-07-30T20:50:35.870Z. Its registry update date was 2019-06-07, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02075606-2019-06-07-2b3824e73b3a"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02075606-2019-06-07-2b3824e73b3a"]}],"sources":[{"id":"ctg-observation-nct02075606-2019-06-07-2b3824e73b3a","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02075606 · retained source version 2019-06-07:2b3824e73b3a07f92b226ecc654333e9b27f5476ec79d2dbbb0b3f4070529ba1","url":"https://clinicaltrials.gov/study/NCT02075606"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"db96227d453b0a41dba366cc3761ae0a2b6ceca5879bbece5dbd4dc56f38bf10","tierARecordSha256":"fad30a2de399d7056aaa46282d4d75884d81d5d9c55dcada7e22fb412780e6e9"},"integrity":{"algorithm":"sha256","contentSha256":"388749d9e77cf94f69a84b29cb2defa2bfaae0c61e0915b40b2082fcee866158"}},"clinicaltrials-gov-nct02127437-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02127437-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct02127437-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02127437-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct02127437-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct02127437-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct02127437-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2026-04-08","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-08","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02127437","sourceIds":["ctg-observation-nct02127437-2026-04-08-acbdbef18222"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02127437 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02127437-2026-04-08-acbdbef18222"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02127437 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02127437-2026-04-08-acbdbef18222"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02127437-2026-04-08-acbdbef18222"]}],"sources":[{"id":"ctg-observation-nct02127437-2026-04-08-acbdbef18222","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02127437 · retained source version 2026-04-08:acbdbef18222cdc0e315be6f3bcad2c924cc7e847957a949ae19c0f2c838587e","url":"https://clinicaltrials.gov/study/NCT02127437"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7dba21ac65b07f48fd7db41d8a11de2b6133a0bd3ac5771bb3b0ae30860f5498","tierARecordSha256":"c0674a96e717933aabc7b42cf3c5d9be3fda1004a2b6623187f5ff59e55905ce"},"integrity":{"algorithm":"sha256","contentSha256":"6223a315c80a31c57bc03a14724cd4957df80297ad4a90c38f6e1a82dd5ffec0"}},"clinicaltrials-gov-nct02351128-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02351128-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct02351128-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02351128-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct02351128-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct02351128-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct02351128-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2017-10-18","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02351128","sourceIds":["ctg-observation-nct02351128-2017-10-18-ec87271a6bae"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02351128 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-10-18, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02351128-2017-10-18-ec87271a6bae"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02351128 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-10-18, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02351128-2017-10-18-ec87271a6bae"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02351128-2017-10-18-ec87271a6bae"]}],"sources":[{"id":"ctg-observation-nct02351128-2017-10-18-ec87271a6bae","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02351128 · retained source version 2017-10-18:ec87271a6bae06eee170df1d4c7cabc50b79dd3eb4bfef3fda7419cb39a9bcd9","url":"https://clinicaltrials.gov/study/NCT02351128"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7cfdc5642937175d7c428f49aa7ff742007acc8365f6d7c214e27cc8e1c2b855","tierARecordSha256":"4ad1880039f071d4393095ef65b963e882d7b3eed461cfec1de3e80bf57c1f90"},"integrity":{"algorithm":"sha256","contentSha256":"752612be30fb4e441d4719c4176a990d76904c35e5c3ce5073b829b649ae26cd"}},"clinicaltrials-gov-nct02493517-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02493517-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct02493517-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02493517-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct02493517-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct02493517-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct02493517-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2019-01-29","sourceCheckedAt":"2026-07-30","publishedAt":"2026-09-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02493517","sourceIds":["ctg-observation-nct02493517-2019-01-29-ab159e4189e7"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02493517 at 2026-07-30T20:57:18.712Z. Its registry update date was 2019-01-29, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02493517-2019-01-29-ab159e4189e7"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02493517 at 2026-07-30T20:57:18.712Z. Its registry update date was 2019-01-29, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct02493517-2019-01-29-ab159e4189e7"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02493517-2019-01-29-ab159e4189e7"]}],"sources":[{"id":"ctg-observation-nct02493517-2019-01-29-ab159e4189e7","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02493517 · retained source version 2019-01-29:ab159e4189e7a6845a8b0ecd4005453044d577dd4d34085c9bb5339142732d4a","url":"https://clinicaltrials.gov/study/NCT02493517"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"85af8580b11d7c8372059c85b58aab278e02b243a876758a73b22424e82dfa6e","tierARecordSha256":"c3783f35636b25c752e6b1c15309a2331dddd1eeaf074c73aff6e7181a167227"},"integrity":{"algorithm":"sha256","contentSha256":"637a62086c938f31e30cfc27743820a5493af21e6e25bc7829837a646ab6c39b"}},"clinicaltrials-gov-nct03012594-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03012594-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct03012594-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03012594-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct03012594-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct03012594-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct03012594-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2021-01-15","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03012594","sourceIds":["ctg-observation-nct03012594-2021-01-15-ef231d4fa94a"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03012594 at 2026-07-30T20:07:13.495Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03012594-2021-01-15-ef231d4fa94a"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03012594 at 2026-07-30T20:07:13.495Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03012594-2021-01-15-ef231d4fa94a"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03012594-2021-01-15-ef231d4fa94a"]}],"sources":[{"id":"ctg-observation-nct03012594-2021-01-15-ef231d4fa94a","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03012594 · retained source version 2021-01-15:ef231d4fa94a131d748fb2b03d110d53ede9fb393aaa0073c5e01de9fa760108","url":"https://clinicaltrials.gov/study/NCT03012594"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"bd7d763bb89b88f9321c4949f000cc87a098836f729e4010a4d55078ca4949f1","tierARecordSha256":"6c8727939ea27f93b7de00b72dc8fc97b47933310f20f8ec098c123926572a26"},"integrity":{"algorithm":"sha256","contentSha256":"266366dd7a2bf398da10c80ab2a44dbfb3d423034b06aaab27011365bf27cd7f"}},"clinicaltrials-gov-nct03043664-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03043664-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct03043664-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03043664-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct03043664-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct03043664-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct03043664-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2023-06-29","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03043664","sourceIds":["ctg-observation-nct03043664-2023-06-29-252649e95e7f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03043664 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03043664-2023-06-29-252649e95e7f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03043664 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03043664-2023-06-29-252649e95e7f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03043664-2023-06-29-252649e95e7f"]}],"sources":[{"id":"ctg-observation-nct03043664-2023-06-29-252649e95e7f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03043664 · retained source version 2023-06-29:252649e95e7f4fc9b21092eb9e1b3acc5c2e74375c9e0e1eb8ef358f57309dde","url":"https://clinicaltrials.gov/study/NCT03043664"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"cb264d6d5cf08e3bd9a94852ab2e1d7dcd4fb1638891ca49ace819846a66c8ae","tierARecordSha256":"59b45ccfe672008358e9f6572944be6a3f0725209c0951cc966990a32f712192"},"integrity":{"algorithm":"sha256","contentSha256":"090dd316135cec53fff5d2d8700db9a6888010949b7f3df6d7f57c73c77019e0"}},"clinicaltrials-gov-nct03158090-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03158090-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct03158090-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03158090-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct03158090-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct03158090-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct03158090-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2022-03-16","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03158090","sourceIds":["ctg-observation-nct03158090-2022-03-16-8e89200a2aed"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03158090 at 2026-07-30T19:42:14.203Z. Its registry update date was 2022-03-16, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03158090-2022-03-16-8e89200a2aed"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03158090 at 2026-07-30T19:42:14.203Z. Its registry update date was 2022-03-16, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03158090-2022-03-16-8e89200a2aed"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03158090-2022-03-16-8e89200a2aed"]}],"sources":[{"id":"ctg-observation-nct03158090-2022-03-16-8e89200a2aed","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03158090 · retained source version 2022-03-16:8e89200a2aed158687ac221171612e0f7c7ce0f117c1810dab1b85fc3cc6b6b3","url":"https://clinicaltrials.gov/study/NCT03158090"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4f9f87a5055cd1d918f6e99eb5b0fe0f81ab7666d0f6f0bdb0e9988a04ebdef7","tierARecordSha256":"23abf0c62992bff5bf96c0aa45c01039191cbc2af74e35d0680becc2f181482d"},"integrity":{"algorithm":"sha256","contentSha256":"00076d25c407ba9ee38fae5e251eafe3936ecfac6993f5e4adf694d00475bed4"}},"clinicaltrials-gov-nct03946527-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03946527-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct03946527-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03946527-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct03946527-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct03946527-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct03946527-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2026-03-02","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03946527","sourceIds":["ctg-observation-nct03946527-2026-03-02-6999199a4838"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03946527 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03946527-2026-03-02-6999199a4838"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03946527 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct03946527-2026-03-02-6999199a4838"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03946527-2026-03-02-6999199a4838"]}],"sources":[{"id":"ctg-observation-nct03946527-2026-03-02-6999199a4838","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03946527 · retained source version 2026-03-02:6999199a4838f40491adfd17965c5915b9a6461947c65106551517b76b6aba2f","url":"https://clinicaltrials.gov/study/NCT03946527"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f23c260dbe9d2edf3ad4fc9ab5f2b3fccf856c07da90a6f7026fb4274bf46df1","tierARecordSha256":"f7a958690e453f103d71e417f5adbf20ec05028f7d0604869284a69ff8ee6456"},"integrity":{"algorithm":"sha256","contentSha256":"381ba047ad39dc70dd0e9397b7e179ed2557abc7a78ee7483b43cf945b94faec"}},"clinicaltrials-gov-nct05048901-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05048901-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct05048901-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05048901-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct05048901-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct05048901-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct05048901-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2026-04-09","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-08","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05048901","sourceIds":["ctg-observation-nct05048901-2026-04-09-469add9afb3b"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05048901 at 2026-07-30T16:20:49.324Z. Its registry update date was 2026-04-09, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct05048901-2026-04-09-469add9afb3b"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05048901 at 2026-07-30T16:20:49.324Z. Its registry update date was 2026-04-09, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct05048901-2026-04-09-469add9afb3b"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05048901-2026-04-09-469add9afb3b"]}],"sources":[{"id":"ctg-observation-nct05048901-2026-04-09-469add9afb3b","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05048901 · retained source version 2026-04-09:469add9afb3b7afbe257162ff7d0c7b3beea435c4a13f4e8edd86bf6b32e000e","url":"https://clinicaltrials.gov/study/NCT05048901"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0d368c8ef595e5b5f5b24dbd4c1d345be8c5a286b1211863d170e185d4104f0f","tierARecordSha256":"6a9a9f6e734045577c4f4be9287a2b71dbbfaa3e0e030c5a0e0902e6ac6d3bf5"},"integrity":{"algorithm":"sha256","contentSha256":"1a78fdd62bda0cb39578ef19d9a79b1f4e40636dc7c045b266136174be168da8"}},"clinicaltrials-gov-nct06807437-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06807437-lanreotide:v1","objectPathId":"clinicaltrials-gov-nct06807437-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06807437-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#clinicaltrials-gov-nct06807437-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#clinicaltrials-gov-nct06807437-lanreotide-v1"},"story":{"slug":"clinicaltrials-gov-nct06807437-lanreotide","version":1,"domain":"Clinical trials","dateInSource":"2026-03-31","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06807437","sourceIds":["ctg-observation-nct06807437-2026-03-31-8f7bf36bed2f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06807437 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct06807437-2026-03-31-8f7bf36bed2f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06807437 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was lanreotide.","sourceIds":["ctg-observation-nct06807437-2026-03-31-8f7bf36bed2f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06807437-2026-03-31-8f7bf36bed2f"]}],"sources":[{"id":"ctg-observation-nct06807437-2026-03-31-8f7bf36bed2f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06807437 · retained source version 2026-03-31:8f7bf36bed2fef244aae2511cfe1d25ca03b98df698cb69c168fef22cc868366","url":"https://clinicaltrials.gov/study/NCT06807437"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4645c47df7bca6b26857da8c098a2288c9ea3e08f1977aae2f2dfe566c2207cc","tierARecordSha256":"0ff38dad593697bbc8663feb2d2d930b2cbbece464df9cf6f1c9edc05ff3d5e4"},"integrity":{"algorithm":"sha256","contentSha256":"7708439276513e305f3da5203e327189298271a667c1771c891bb2aa816237f6"}},"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1:v1","objectPathId":"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-v1"},"story":{"slug":"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1","version":1,"domain":"Regulatory","dateInSource":"2024-05-23","sourceCheckedAt":"2026-08-22","publishedAt":"2026-08-22","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Lanreotide DailyMed SPL version 1","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-history"]},{"id":"summary","text":"DailyMed lists Structured Product Labeling version 1 for the reviewed Lanreotide label family with a published date of 2024-05-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-history"]},{"id":"paragraph-1","text":"DailyMed lists Structured Product Labeling version 1 for the reviewed Lanreotide label family with a published date of 2024-05-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-history"]},{"id":"paragraph-2","text":"This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-history"]}],"sources":[{"id":"dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v1-history","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"DailyMed SPL SET ID 2892b4c3-0329-4d29-97ff-3b45283bbab1 · SPL version 1 · published 2024-05-23 · retained ZIP SHA-256 61b9a71fe22e8bfa99d826e900c981bd71710e9b35882f2d27565b4eda878837","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=2892b4c3-0329-4d29-97ff-3b45283bbab1&version=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"93d6feee3373f9caa06be9bdf3b83088ea0df2432d7ab5166f292ffd03c9be81","tierARecordSha256":"a730ab2e47a701a61f6ca805ec39a633552ebbd6703969878c7be2de67a6923b"},"integrity":{"algorithm":"sha256","contentSha256":"b677b597cab2f3798a6a94719d4d0ed32a287e425d394e085a1b373f5a94fb08"}},"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2:v1","objectPathId":"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-v1"},"story":{"slug":"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2","version":1,"domain":"Regulatory","dateInSource":"2024-12-02","sourceCheckedAt":"2026-08-22","publishedAt":"2026-08-22","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Lanreotide DailyMed SPL version 2","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-history"]},{"id":"summary","text":"DailyMed lists Structured Product Labeling version 2 for the reviewed Lanreotide label family with a published date of 2024-12-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-history"]},{"id":"paragraph-1","text":"DailyMed lists Structured Product Labeling version 2 for the reviewed Lanreotide label family with a published date of 2024-12-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-history"]},{"id":"paragraph-2","text":"This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-history"]}],"sources":[{"id":"dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v2-history","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"DailyMed SPL SET ID 2892b4c3-0329-4d29-97ff-3b45283bbab1 · SPL version 2 · published 2024-12-02 · retained ZIP SHA-256 80a2a89da89f8f25c8bd12c1437d5466f86080a346f87ea3c4d8abf9936eae49","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=2892b4c3-0329-4d29-97ff-3b45283bbab1&version=2"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7d5222e35dd7758aa22309e8e3b3b307aacfe7c8f59a31059f2ec9bb1bfbc2c4","tierARecordSha256":"7cec5f8bf9c9e9904213786adbe67cdc618c3614c637fea827e25ee0ad082af3"},"integrity":{"algorithm":"sha256","contentSha256":"812b0b5c18c603c6ed6e93cb293013dc71245071cc82718f2b12e06573948f6f"}},"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3:v1","objectPathId":"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-v1"},"story":{"slug":"dailymed-label-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3","version":1,"domain":"Regulatory","dateInSource":"2025-06-02","sourceCheckedAt":"2026-08-22","publishedAt":"2026-08-22","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Lanreotide DailyMed SPL version 3","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-history"]},{"id":"summary","text":"DailyMed lists Structured Product Labeling version 3 for the reviewed Lanreotide label family with a published date of 2025-06-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-history"]},{"id":"paragraph-1","text":"DailyMed lists Structured Product Labeling version 3 for the reviewed Lanreotide label family with a published date of 2025-06-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-history"]},{"id":"paragraph-2","text":"This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance.","sourceIds":["dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-history"]}],"sources":[{"id":"dailymed-lanreotide-2892b4c3-0329-4d29-97ff-3b45283bbab1-v3-history","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"DailyMed SPL SET ID 2892b4c3-0329-4d29-97ff-3b45283bbab1 · SPL version 3 · published 2025-06-02 · retained ZIP SHA-256 549b28079c4ff34c485706fc6353164f8e1903e90a1ec7f10f97482b441b0bfe","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=2892b4c3-0329-4d29-97ff-3b45283bbab1&version=3"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9686de5a220c49d25ae4af8df01276c7f468027571779234395657770c410247","tierARecordSha256":"05beeaf73af3775898428597590aaa95cd3edca1c9331cf6177eead801250c19"},"integrity":{"algorithm":"sha256","contentSha256":"2cb0d8de18461e5d510616a8eccd8ea69fa557679ace8a50336089e4d0ec85dd"}},"fda-drugs-anda217193-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-anda217193:v1","objectPathId":"fda-drugs-anda217193-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-anda217193/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#fda-drugs-anda217193-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#fda-drugs-anda217193-v1"},"story":{"slug":"fda-drugs-anda217193","version":1,"domain":"Regulatory","dateInSource":"2024-05-21","sourceCheckedAt":"2026-08-14","publishedAt":"2026-08-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application ANDA217193","sourceIds":["fda-drugs-anda217193-2024-05-21-688e02d085c4"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for ANDA 217193 with status AP dated 2024-05-21, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-anda217193-2024-05-21-688e02d085c4"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for ANDA 217193 with status AP dated 2024-05-21, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-anda217193-2024-05-21-688e02d085c4"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-anda217193-2024-05-21-688e02d085c4"]}],"sources":[{"id":"fda-drugs-anda217193-2024-05-21-688e02d085c4","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application ANDA217193 · original submission status AP · 2024-05-21 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22ANDA217193%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"28ab4957e13a517a38ce1a33e70a4bc7ec295e6580544168d91117f83e486cb2","tierARecordSha256":"688e02d085c4832e58ae437c1e551ec85ec78475b8e81a881c771efe55deefc8"},"integrity":{"algorithm":"sha256","contentSha256":"2a57a35ce319f7afa34a0b041731bfa0ff1e2885a7aa46d769a1b9c9627ac091"}},"fda-drugs-anda218217-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-anda218217:v1","objectPathId":"fda-drugs-anda218217-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-anda218217/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#fda-drugs-anda218217-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#fda-drugs-anda218217-v1"},"story":{"slug":"fda-drugs-anda218217","version":1,"domain":"Regulatory","dateInSource":"2026-09-18","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application ANDA218217","sourceIds":["fda-drugs-anda218217-2026-09-18-3ea852e35740"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for ANDA 218217 with status AP dated 2026-09-18, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-anda218217-2026-09-18-3ea852e35740"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for ANDA 218217 with status AP dated 2026-09-18, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-anda218217-2026-09-18-3ea852e35740"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-anda218217-2026-09-18-3ea852e35740"]}],"sources":[{"id":"fda-drugs-anda218217-2026-09-18-3ea852e35740","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application ANDA218217 · original submission status AP · 2026-09-18 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22ANDA218217%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7cbe6ce6120074da092b8dd4e4878ce153e12a3f47f40a80e5daa76c81358ddb","tierARecordSha256":"3ea852e357405473a442133e2afdcccf3ec4ec88ac99a4fb3921a4b4e547c0d8"},"integrity":{"algorithm":"sha256","contentSha256":"b4df819539eb97c81b01d71b3b36705840036eb8988d8a01c58ad24b354b0227"}},"fda-drugs-nda022074-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda022074:v1","objectPathId":"fda-drugs-nda022074-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda022074/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#fda-drugs-nda022074-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#fda-drugs-nda022074-v1"},"story":{"slug":"fda-drugs-nda022074","version":1,"domain":"Regulatory","dateInSource":"2007-08-30","sourceCheckedAt":"2026-08-14","publishedAt":"2026-08-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA022074","sourceIds":["fda-drugs-nda022074-2007-08-30-439ff00e36be"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 022074 with status AP dated 2007-08-30, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda022074-2007-08-30-439ff00e36be"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 022074 with status AP dated 2007-08-30, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda022074-2007-08-30-439ff00e36be"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda022074-2007-08-30-439ff00e36be"]}],"sources":[{"id":"fda-drugs-nda022074-2007-08-30-439ff00e36be","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA022074 · original submission status AP · 2007-08-30 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA022074%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"865fca24f96f3d89314e49475bb2badb85933e071126764da6b63cc01912153f","tierARecordSha256":"439ff00e36be79cc4fa70bb99cb87f0ac24a5e1b0158fbf9bce5b3bfe7efdc29"},"integrity":{"algorithm":"sha256","contentSha256":"210d6c49cb1309e23c673529862324cdb8672f8e1572161948bb9bb1510f54d7"}},"fda-drugs-nda215395-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda215395:v1","objectPathId":"fda-drugs-nda215395-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda215395/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#fda-drugs-nda215395-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#fda-drugs-nda215395-v1"},"story":{"slug":"fda-drugs-nda215395","version":1,"domain":"Regulatory","dateInSource":"2021-12-17","sourceCheckedAt":"2026-08-14","publishedAt":"2026-08-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA215395","sourceIds":["fda-drugs-nda215395-2021-12-17-2de401fe75fc"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 215395 with status AP dated 2021-12-17, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda215395-2021-12-17-2de401fe75fc"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 215395 with status AP dated 2021-12-17, and names lanreotide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda215395-2021-12-17-2de401fe75fc"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda215395-2021-12-17-2de401fe75fc"]}],"sources":[{"id":"fda-drugs-nda215395-2021-12-17-2de401fe75fc","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA215395 · original submission status AP · 2021-12-17 · dataset 2026-08-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA215395%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f15aae79d34a2a637776e224f40586e2ec07f817512505b40dd4a2a82bda8b2a","tierARecordSha256":"2de401fe75fc4edc9cc896dec60c925581a282b9b086c55803e99e986a15be03"},"integrity":{"algorithm":"sha256","contentSha256":"9c033d279294971df1601bb1f7c1e1f6e736de2b82b4613e03cfeb2287aadf29"}},"fda-enforcement-d-0290-2026-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-enforcement-d-0290-2026:v1","objectPathId":"fda-enforcement-d-0290-2026-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-enforcement-d-0290-2026/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#fda-enforcement-d-0290-2026-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#fda-enforcement-d-0290-2026-v1"},"story":{"slug":"fda-enforcement-d-0290-2026","version":1,"domain":"Safety","dateInSource":"2026-01-21","sourceCheckedAt":"2026-08-25","publishedAt":"2026-08-25","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"FDA enforcement report D-0290-2026","sourceIds":["fda-enforcement-d-0290-2026-aa4de191d243"]},{"id":"summary","text":"FDA's dated enforcement report D-0290-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.","sourceIds":["fda-enforcement-d-0290-2026-aa4de191d243"]},{"id":"paragraph-1","text":"FDA's dated enforcement report D-0290-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.","sourceIds":["fda-enforcement-d-0290-2026-aa4de191d243"]},{"id":"paragraph-2","text":"FDA's source-reported reason is: Presence of Particulate Matter.","sourceIds":["fda-enforcement-d-0290-2026-aa4de191d243"]},{"id":"paragraph-3","text":"This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance.","sourceIds":["fda-enforcement-d-0290-2026-aa4de191d243"]}],"sources":[{"id":"fda-enforcement-d-0290-2026-aa4de191d243","name":"FDA enforcement reports via openFDA","sourceClass":"A","title":"FDA enforcement report D-0290-2026 · Class II · report date 2026-01-21 · source status Ongoing","url":"https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0290-2026%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited safety or enforcement record. It is not an individualized risk assessment or medical recommendation.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0e93734525a7d7da535398e20b8ad347ca57593f0438ebddb82dc756b9497957","tierARecordSha256":"aa4de191d24345e8f21167a2ef29341f98b846af1beaf48680cb62dfe78aed32"},"integrity":{"algorithm":"sha256","contentSha256":"e8bef98e1214b4889f4273b8c05269acc07eec6a7a2131f840a29d9d5417256a"}},"fda-enforcement-d-0422-2026-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-enforcement-d-0422-2026:v1","objectPathId":"fda-enforcement-d-0422-2026-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-enforcement-d-0422-2026/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#fda-enforcement-d-0422-2026-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#fda-enforcement-d-0422-2026-v1"},"story":{"slug":"fda-enforcement-d-0422-2026","version":1,"domain":"Safety","dateInSource":"2026-04-15","sourceCheckedAt":"2026-08-25","publishedAt":"2026-08-25","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"FDA enforcement report D-0422-2026","sourceIds":["fda-enforcement-d-0422-2026-36fc7f6a6b04"]},{"id":"summary","text":"FDA's dated enforcement report D-0422-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.","sourceIds":["fda-enforcement-d-0422-2026-36fc7f6a6b04"]},{"id":"paragraph-1","text":"FDA's dated enforcement report D-0422-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application NDA215395 through exact openFDA application-number annotations.","sourceIds":["fda-enforcement-d-0422-2026-36fc7f6a6b04"]},{"id":"paragraph-2","text":"FDA's source-reported reason is: Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.","sourceIds":["fda-enforcement-d-0422-2026-36fc7f6a6b04"]},{"id":"paragraph-3","text":"This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance.","sourceIds":["fda-enforcement-d-0422-2026-36fc7f6a6b04"]}],"sources":[{"id":"fda-enforcement-d-0422-2026-36fc7f6a6b04","name":"FDA enforcement reports via openFDA","sourceClass":"A","title":"FDA enforcement report D-0422-2026 · Class II · report date 2026-04-15 · source status Ongoing","url":"https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0422-2026%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited safety or enforcement record. It is not an individualized risk assessment or medical recommendation.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9555ac215b4418a6330eaf0befe387ac268ba6ad4a5dea441582d52a4dcc248a","tierARecordSha256":"36fc7f6a6b04c06d7292134ce07f0a33dd25424440e470976801cc187467f932"},"integrity":{"algorithm":"sha256","contentSha256":"31767245fbf6879a59e2e1e5dd90ed5e8c20b5074e2306a1cc4bd2f882178fad"}},"fda-enforcement-d-0423-2026-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-enforcement-d-0423-2026:v1","objectPathId":"fda-enforcement-d-0423-2026-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-enforcement-d-0423-2026/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#fda-enforcement-d-0423-2026-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#fda-enforcement-d-0423-2026-v1"},"story":{"slug":"fda-enforcement-d-0423-2026","version":1,"domain":"Safety","dateInSource":"2026-04-15","sourceCheckedAt":"2026-08-25","publishedAt":"2026-08-25","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"FDA enforcement report D-0423-2026","sourceIds":["fda-enforcement-d-0423-2026-cdc37a992e40"]},{"id":"summary","text":"FDA's dated enforcement report D-0423-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application ANDA217193 through exact openFDA application-number annotations.","sourceIds":["fda-enforcement-d-0423-2026-cdc37a992e40"]},{"id":"paragraph-1","text":"FDA's dated enforcement report D-0423-2026 lists Class II and source status Ongoing for Cipla USA, Inc. PeptideScanner connects the report to reviewed application ANDA217193 through exact openFDA application-number annotations.","sourceIds":["fda-enforcement-d-0423-2026-cdc37a992e40"]},{"id":"paragraph-2","text":"FDA's source-reported reason is: Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.","sourceIds":["fda-enforcement-d-0423-2026-cdc37a992e40"]},{"id":"paragraph-3","text":"This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance.","sourceIds":["fda-enforcement-d-0423-2026-cdc37a992e40"]}],"sources":[{"id":"fda-enforcement-d-0423-2026-cdc37a992e40","name":"FDA enforcement reports via openFDA","sourceClass":"A","title":"FDA enforcement report D-0423-2026 · Class II · report date 2026-04-15 · source status Ongoing","url":"https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0423-2026%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited safety or enforcement record. It is not an individualized risk assessment or medical recommendation.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f87fb5db8d274e31b1b75ec236db7600a31bc5897c66ac76b5a93184e5169737","tierARecordSha256":"cdc37a992e407d8df1c2f4d3551d387e5aa1f78e6a78f4e1c1c270504ff12dee"},"integrity":{"algorithm":"sha256","contentSha256":"d57b3ce3826fd94f33f109d18e30ed87981339dcbc576f1afb91b352c002e820"}},"federal-register-2014-17293-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2014-17293:v1","objectPathId":"federal-register-2014-17293-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2014-17293/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#federal-register-2014-17293-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#federal-register-2014-17293-v1"},"story":{"slug":"federal-register-2014-17293","version":1,"domain":"Regulatory","dateInSource":"2014-07-23","sourceCheckedAt":"2026-08-21","publishedAt":"2026-08-21","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2014-17293","sourceIds":["federal-register-2014-17293-1eaf93c9c601"]},{"id":"summary","text":"The Federal Register published notice 2014-17293, attributed to FDA and its parent HHS department, on 2014-07-23. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.","sourceIds":["federal-register-2014-17293-1eaf93c9c601"]},{"id":"paragraph-1","text":"The Federal Register published notice 2014-17293, attributed to FDA and its parent HHS department, on 2014-07-23. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.","sourceIds":["federal-register-2014-17293-1eaf93c9c601"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2014-17293-1eaf93c9c601"]}],"sources":[{"id":"federal-register-2014-17293-1eaf93c9c601","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2014-17293 · published 2014-07-23 · Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability","url":"https://www.govinfo.gov/content/pkg/FR-2014-07-23/pdf/2014-17293.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"308d2b17b1a32f89fa65a4d3cf51a9dbe138f355bfd87c11f709dc3d2ca75311","tierARecordSha256":"1eaf93c9c6011d238c194f2342c07f5408a44b34f90dd7656f31f9dc347625c2"},"integrity":{"algorithm":"sha256","contentSha256":"7f055dd2cca939ab3359d5e7e556cde7cff629d32a7ecf2b2a26be222fe93252"}},"federal-register-e8-27179-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-e8-27179:v1","objectPathId":"federal-register-e8-27179-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-e8-27179/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#federal-register-e8-27179-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#federal-register-e8-27179-v1"},"story":{"slug":"federal-register-e8-27179","version":1,"domain":"Regulatory","dateInSource":"2008-11-17","sourceCheckedAt":"2026-08-21","publishedAt":"2026-08-21","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Federal Register notice E8-27179","sourceIds":["federal-register-e8-27179-91fe25f7d5e5"]},{"id":"summary","text":"The Federal Register published notice E8-27179, attributed to FDA and its parent HHS department, on 2008-11-17. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.","sourceIds":["federal-register-e8-27179-91fe25f7d5e5"]},{"id":"paragraph-1","text":"The Federal Register published notice E8-27179, attributed to FDA and its parent HHS department, on 2008-11-17. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.","sourceIds":["federal-register-e8-27179-91fe25f7d5e5"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-e8-27179-91fe25f7d5e5"]}],"sources":[{"id":"federal-register-e8-27179-91fe25f7d5e5","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice E8-27179 · published 2008-11-17 · Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT","url":"https://www.govinfo.gov/content/pkg/FR-2008-11-17/pdf/E8-27179.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"99359c6bce75085e64176dc9146e3385d6f5587f673177b91907405e5899a71b","tierARecordSha256":"91fe25f7d5e5b072bfa021527fc1d6fa931ed5fd7d62414c5c710147a442dda9"},"integrity":{"algorithm":"sha256","contentSha256":"fb9095c989b6e39b95529d645da102ad4cb7a99d9040111f7ca0e790911028ca"}},"pubmed-pmid-10199803-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-10199803-lanreotide:v1","objectPathId":"pubmed-pmid-10199803-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-10199803-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-10199803-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-10199803-lanreotide-v1"},"story":{"slug":"pubmed-pmid-10199803-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 10199803","sourceIds":["pubmed-observation-pmid-10199803-2016-11-24-76dea1f92561"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10199803 at 2026-07-30T21:35:52.336Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-04-13. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10199803-2016-11-24-76dea1f92561"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10199803 at 2026-07-30T21:35:52.336Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-04-13. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10199803-2016-11-24-76dea1f92561"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-10199803-2016-11-24-76dea1f92561"]}],"sources":[{"id":"pubmed-observation-pmid-10199803-2016-11-24-76dea1f92561","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 10199803 · retained source version 1:2016-11-24:current:76dea1f9256112b5eda8a255d04c9423185ffaed69ddb48a1990c5e8257af88b","url":"https://pubmed.ncbi.nlm.nih.gov/10199803/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"28595766b3aaef9139037f2b172264f63c6bc11145440d0239b38f2bb2df4fe7","tierARecordSha256":"b13c9b63ae60c8dc48ffe30b5d0bc2b1183a64006d6c5a288c44643f19a66c82"},"integrity":{"algorithm":"sha256","contentSha256":"4701c3ea679efa8a709ac8a9c118018f4c010f8f6a59dbdac6d4dc47dbca7a08"}},"pubmed-pmid-10231313-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-10231313-lanreotide:v1","objectPathId":"pubmed-pmid-10231313-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-10231313-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-10231313-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-10231313-lanreotide-v1"},"story":{"slug":"pubmed-pmid-10231313-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 10231313","sourceIds":["pubmed-observation-pmid-10231313-2016-11-24-178cd55ce816"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10231313 at 2026-07-30T21:35:52.337Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-05-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10231313-2016-11-24-178cd55ce816"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10231313 at 2026-07-30T21:35:52.337Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-05-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10231313-2016-11-24-178cd55ce816"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-10231313-2016-11-24-178cd55ce816"]}],"sources":[{"id":"pubmed-observation-pmid-10231313-2016-11-24-178cd55ce816","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 10231313 · retained source version 1:2016-11-24:current:178cd55ce816401ca205e1489151ed72fd7a9b5989ba13d4869fc9a3e3a18639","url":"https://pubmed.ncbi.nlm.nih.gov/10231313/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5422d363974a9b02d971ea6aa0a01e8f1b0adbbc134c51c287a7bee7aa6296b0","tierARecordSha256":"a5ad0f693539df9f9325ceda6076af0224bab2382d8b98e11b006b1d1b080465"},"integrity":{"algorithm":"sha256","contentSha256":"c6d86efa74af0ccde15905443396f3f8ab84a7a1106fc6fad5d91d510d1695f9"}},"pubmed-pmid-10480146-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-10480146-lanreotide:v1","objectPathId":"pubmed-pmid-10480146-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-10480146-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-10480146-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-10480146-lanreotide-v1"},"story":{"slug":"pubmed-pmid-10480146-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 10480146","sourceIds":["pubmed-observation-pmid-10480146-2016-11-24-a6992ef38b33"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10480146 at 2026-07-30T21:35:52.338Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-09-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10480146-2016-11-24-a6992ef38b33"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10480146 at 2026-07-30T21:35:52.338Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-09-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10480146-2016-11-24-a6992ef38b33"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-10480146-2016-11-24-a6992ef38b33"]}],"sources":[{"id":"pubmed-observation-pmid-10480146-2016-11-24-a6992ef38b33","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 10480146 · retained source version 1:2016-11-24:current:a6992ef38b334ea48031c7529594c6f1460d44f376a78659b8b6ce56f4089d3f","url":"https://pubmed.ncbi.nlm.nih.gov/10480146/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8c5c402c73fcc8db46d965d258470d04e0a45e6eeb09f81f62cb9f73ca273f1d","tierARecordSha256":"92498b1c19b3c3136bbaac38d56f0d03aebee32bb1d283ccd89add1b0217c76f"},"integrity":{"algorithm":"sha256","contentSha256":"26aec1e623d04930d14930b6ef6165654bd89198f0cf11b416df35ed616eff9f"}},"pubmed-pmid-10579475-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-10579475-lanreotide:v1","objectPathId":"pubmed-pmid-10579475-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-10579475-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-10579475-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-10579475-lanreotide-v1"},"story":{"slug":"pubmed-pmid-10579475-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 10579475","sourceIds":["pubmed-observation-pmid-10579475-2016-11-24-df147568030c"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10579475 at 2026-07-30T21:35:52.340Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10579475-2016-11-24-df147568030c"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10579475 at 2026-07-30T21:35:52.340Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10579475-2016-11-24-df147568030c"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-10579475-2016-11-24-df147568030c"]}],"sources":[{"id":"pubmed-observation-pmid-10579475-2016-11-24-df147568030c","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 10579475 · retained source version 1:2016-11-24:current:df147568030cab6debe59bddb1c407a0237df703ef60b49b71908ad6f9eddb5e","url":"https://pubmed.ncbi.nlm.nih.gov/10579475/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c38b571fd43f9c1bba09c4eaa31650e1a01cfbc4fc7058e3e2fa0bcfc80cede3","tierARecordSha256":"0769d86613eda31500754a6433184a822cda137d311c0bac148762d9c0d94852"},"integrity":{"algorithm":"sha256","contentSha256":"f270ba261fb897d8cf9934510ed7aef53285cc6a921b98d9ec4703807d7551b0"}},"pubmed-pmid-10748802-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-10748802-lanreotide:v1","objectPathId":"pubmed-pmid-10748802-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-10748802-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-10748802-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-10748802-lanreotide-v1"},"story":{"slug":"pubmed-pmid-10748802-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 10748802","sourceIds":["pubmed-observation-pmid-10748802-2016-11-24-b9eb4c4764bf"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10748802 at 2026-07-30T21:35:52.342Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-04-05. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10748802-2016-11-24-b9eb4c4764bf"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 10748802 at 2026-07-30T21:35:52.342Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-04-05. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-10748802-2016-11-24-b9eb4c4764bf"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-10748802-2016-11-24-b9eb4c4764bf"]}],"sources":[{"id":"pubmed-observation-pmid-10748802-2016-11-24-b9eb4c4764bf","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 10748802 · retained source version 1:2016-11-24:current:b9eb4c4764bf8767e9032aebf1a3a2d299f9ce1c52145f2108953a1b27b5c549","url":"https://pubmed.ncbi.nlm.nih.gov/10748802/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"24558cb02409dee7d13fd824c126d5e45c3ae891ce52019466a1f566fd61705b","tierARecordSha256":"89fea986dc0116528acef79d33fa5cfef92afd8e1d33e53f91c65052d2fc2d6d"},"integrity":{"algorithm":"sha256","contentSha256":"d942bf4256313de3c390be3224a8352581a15f54c114d07bee84cc3c98f78943"}},"pubmed-pmid-11095353-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-11095353-lanreotide:v1","objectPathId":"pubmed-pmid-11095353-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-11095353-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-11095353-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-11095353-lanreotide-v1"},"story":{"slug":"pubmed-pmid-11095353-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 11095353","sourceIds":["pubmed-observation-pmid-11095353-2016-11-24-335788b8d858"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 11095353 at 2026-07-30T21:35:52.345Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-11-30. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-11095353-2016-11-24-335788b8d858"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 11095353 at 2026-07-30T21:35:52.345Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-11-30. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-11095353-2016-11-24-335788b8d858"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-11095353-2016-11-24-335788b8d858"]}],"sources":[{"id":"pubmed-observation-pmid-11095353-2016-11-24-335788b8d858","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 11095353 · retained source version 1:2016-11-24:current:335788b8d858df99a7bbfcfcd803f0ab5c9f267069b529f99cca7ac417d81819","url":"https://pubmed.ncbi.nlm.nih.gov/11095353/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"cac83ff3d312e72c2be71462abfada33ce9393c97580eebb7491339d55f8d3a9","tierARecordSha256":"b036a73eedf622b6119b4118f0e92694e6b7d7353d58d2e3ba7ed0123914ee59"},"integrity":{"algorithm":"sha256","contentSha256":"70f2482c0dbce03b9848a4989b2effc3ae48329d28c3a2c05f81c869eee39b3c"}},"pubmed-pmid-11128563-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-11128563-lanreotide:v1","objectPathId":"pubmed-pmid-11128563-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-11128563-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-11128563-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-11128563-lanreotide-v1"},"story":{"slug":"pubmed-pmid-11128563-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 11128563","sourceIds":["pubmed-observation-pmid-11128563-2016-11-24-fd723ce8d43a"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 11128563 at 2026-07-30T21:35:52.346Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-11128563-2016-11-24-fd723ce8d43a"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 11128563 at 2026-07-30T21:35:52.346Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-11128563-2016-11-24-fd723ce8d43a"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-11128563-2016-11-24-fd723ce8d43a"]}],"sources":[{"id":"pubmed-observation-pmid-11128563-2016-11-24-fd723ce8d43a","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 11128563 · retained source version 1:2016-11-24:current:fd723ce8d43acff90a3d9d66dda6f4b6eba7e0a56024515e5b4a750cf3fccfaf","url":"https://pubmed.ncbi.nlm.nih.gov/11128563/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"35acf9223d2ff0677a6bc242e4635dc52f214d58fe4de328c447c3f8d62775ee","tierARecordSha256":"145c40acb32eb194ecfe8dca6b3da4eb92738ef6447072848b6514df71196c0c"},"integrity":{"algorithm":"sha256","contentSha256":"a6400eb71ada062c5a4c89851aa9cd660d459f568fe82147e8295193aec526fc"}},"pubmed-pmid-12037499-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-12037499-lanreotide:v1","objectPathId":"pubmed-pmid-12037499-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-12037499-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-12037499-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-12037499-lanreotide-v1"},"story":{"slug":"pubmed-pmid-12037499-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"[Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients].","sourceIds":["pubmed-observation-pmid-12037499-2016-11-24-270de4f82007"]},{"id":"summary","text":"PubMed lists PMID 12037499 in Annales d'endocrinologie as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2002-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-12037499-2016-11-24-270de4f82007"]},{"id":"paragraph-1","text":"PubMed lists PMID 12037499 in Annales d'endocrinologie as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2002-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-12037499-2016-11-24-270de4f82007"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-12037499-2016-11-24-270de4f82007"]}],"sources":[{"id":"pubmed-observation-pmid-12037499-2016-11-24-270de4f82007","name":"PubMed","sourceClass":"A","title":"[Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients]. · retained source version 1:2016-11-24:current:270de4f82007e9e9aa2a6bfbc26aae2ad1b2b3cfef7893bb3030174c3c8232a0","url":"https://pubmed.ncbi.nlm.nih.gov/12037499/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e1ddc812d5f19e6c0ede21144fb3f4635427fb76c8e629fb93705d23889e49fe","tierARecordSha256":"96dd630e3871c62c8b1b1d46ddf224351a67a08fb5fc910ae1d55255b023562c"},"integrity":{"algorithm":"sha256","contentSha256":"b562c337fa0bddc1e1e09401ce5cc3e3347de72ab99f12e35b8160035c66f505"}},"pubmed-pmid-15003204-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15003204-lanreotide:v1","objectPathId":"pubmed-pmid-15003204-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15003204-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-15003204-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-15003204-lanreotide-v1"},"story":{"slug":"pubmed-pmid-15003204-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2014-08-18","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-10","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 15003204","sourceIds":["pubmed-observation-pmid-15003204-2014-08-18-c1124084b671"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 15003204 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-08-18 and an Entrez history date of 2004-03-09. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-15003204-2014-08-18-c1124084b671"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 15003204 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-08-18 and an Entrez history date of 2004-03-09. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-15003204-2014-08-18-c1124084b671"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15003204-2014-08-18-c1124084b671"]}],"sources":[{"id":"pubmed-observation-pmid-15003204-2014-08-18-c1124084b671","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 15003204 · retained source version 1:2014-08-18:current:c1124084b6718c6e8c4e4c47d5c3d2141c219b4eb4d3736c70184334f9ceb46c","url":"https://pubmed.ncbi.nlm.nih.gov/15003204/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"06684080e2a2ab66f8c481abbd565a0447657ac78ec5dc4e452d680c9d3b4b5e","tierARecordSha256":"bceb5c5ef409349003adf9bc4ac105909a743ff1e1278f1c071aed4390dd17bd"},"integrity":{"algorithm":"sha256","contentSha256":"8ce7e339bc3b2e9d6afc0e08ae495e97fc5bad46e08aa8339add5cf22729bb40"}},"pubmed-pmid-15789272-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15789272-lanreotide:v1","objectPathId":"pubmed-pmid-15789272-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15789272-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-15789272-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-15789272-lanreotide-v1"},"story":{"slug":"pubmed-pmid-15789272-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel).","sourceIds":["pubmed-observation-pmid-15789272-2026-01-28-d803d8ef110c"]},{"id":"summary","text":"PubMed lists PMID 15789272 in Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association as Journal Article, with publication-date metadata of 2005-03 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15789272-2026-01-28-d803d8ef110c"]},{"id":"paragraph-1","text":"PubMed lists PMID 15789272 in Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association as Journal Article, with publication-date metadata of 2005-03 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15789272-2026-01-28-d803d8ef110c"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15789272-2026-01-28-d803d8ef110c"]}],"sources":[{"id":"pubmed-observation-pmid-15789272-2026-01-28-d803d8ef110c","name":"PubMed","sourceClass":"A","title":"Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel). · retained source version 1:2026-01-28:current:d803d8ef110c4653974c3a80952a3dd6ed0c8cc7285052ddf28a26605502340c","url":"https://pubmed.ncbi.nlm.nih.gov/15789272/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"876a2e78d4788724bc4de1628e09b0451c97e786f1f7f89fc68fc168f72389e2","tierARecordSha256":"0833acdb34db4b5d5b7729e450c0a93bfc3bc554f980154c259b51ef52834a09"},"integrity":{"algorithm":"sha256","contentSha256":"90b96a4347d8a8bcab99dd1fd2b7860758db08a9db60c614ceab506b54c82de7"}},"pubmed-pmid-15789913-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-15789913-lanreotide:v1","objectPathId":"pubmed-pmid-15789913-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-15789913-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-15789913-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-15789913-lanreotide-v1"},"story":{"slug":"pubmed-pmid-15789913-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"[Lanreotide in the treatment of thyroid orbitopathy].","sourceIds":["pubmed-observation-pmid-15789913-2016-11-24-5aa6edd1b8ce"]},{"id":"summary","text":"PubMed lists PMID 15789913 in Przeglad lekarski as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15789913-2016-11-24-5aa6edd1b8ce"]},{"id":"paragraph-1","text":"PubMed lists PMID 15789913 in Przeglad lekarski as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-15789913-2016-11-24-5aa6edd1b8ce"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-15789913-2016-11-24-5aa6edd1b8ce"]}],"sources":[{"id":"pubmed-observation-pmid-15789913-2016-11-24-5aa6edd1b8ce","name":"PubMed","sourceClass":"A","title":"[Lanreotide in the treatment of thyroid orbitopathy]. · retained source version 1:2016-11-24:current:5aa6edd1b8ced1b7081a988ecceac30ae1db1656dd7a9d1bc88c71acaa6434ac","url":"https://pubmed.ncbi.nlm.nih.gov/15789913/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"598d338d5d2f6c3c8a48809152f585dbe3fd6d3bd74c7e8ead35ae69ac17de71","tierARecordSha256":"79935c758b56ac20533afe1add476cb355c796bc9a47c804f7397ac575beb2db"},"integrity":{"algorithm":"sha256","contentSha256":"937aac4405a09b46e84a69df7b1e4c65dffda6d6d89eba826df1bf8952c3c023"}},"pubmed-pmid-16154424-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-16154424-lanreotide:v1","objectPathId":"pubmed-pmid-16154424-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-16154424-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-16154424-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-16154424-lanreotide-v1"},"story":{"slug":"pubmed-pmid-16154424-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Pharmacokinetics and population pharmacodynamic analysis of lanreotide Autogel.","sourceIds":["pubmed-observation-pmid-16154424-2016-11-24-de7345724055"]},{"id":"summary","text":"PubMed lists PMID 16154424 in Metabolism: clinical and experimental as Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-16154424-2016-11-24-de7345724055"]},{"id":"paragraph-1","text":"PubMed lists PMID 16154424 in Metabolism: clinical and experimental as Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-16154424-2016-11-24-de7345724055"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-16154424-2016-11-24-de7345724055"]}],"sources":[{"id":"pubmed-observation-pmid-16154424-2016-11-24-de7345724055","name":"PubMed","sourceClass":"A","title":"Pharmacokinetics and population pharmacodynamic analysis of lanreotide Autogel. · retained source version 1:2016-11-24:current:de734572405555069515bd20bf569a8f4ab82dab8cdfe697b81e65b01b8cdc07","url":"https://pubmed.ncbi.nlm.nih.gov/16154424/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ee53da7f9f1dcb2f22a65fb13bb0857af6f4624990d2f6134331cc8950088140","tierARecordSha256":"222cfc6f0a709e5d5d85203cc5ab4d4d4871f1c77ac9fba222e15a02125c47c5"},"integrity":{"algorithm":"sha256","contentSha256":"3a9c543d560d1de0d60038497a41ef01f2c981fa25bd809b5020697a76755b2d"}},"pubmed-pmid-17854356-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17854356-lanreotide:v1","objectPathId":"pubmed-pmid-17854356-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17854356-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-17854356-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-17854356-lanreotide-v1"},"story":{"slug":"pubmed-pmid-17854356-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide.","sourceIds":["pubmed-observation-pmid-17854356-2016-11-24-41f5c924b7a1"]},{"id":"summary","text":"PubMed lists PMID 17854356 in The British journal of dermatology as Case Reports, Letter, with publication-date metadata of 2007-09-13 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17854356-2016-11-24-41f5c924b7a1"]},{"id":"paragraph-1","text":"PubMed lists PMID 17854356 in The British journal of dermatology as Case Reports, Letter, with publication-date metadata of 2007-09-13 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17854356-2016-11-24-41f5c924b7a1"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17854356-2016-11-24-41f5c924b7a1"]}],"sources":[{"id":"pubmed-observation-pmid-17854356-2016-11-24-41f5c924b7a1","name":"PubMed","sourceClass":"A","title":"Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide. · retained source version 1:2016-11-24:current:41f5c924b7a1f84c41e17edc6c5d700a24d57f42069129c82d2ae3ae65c7a91e","url":"https://pubmed.ncbi.nlm.nih.gov/17854356/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"aaa54fb1a1048da95b1d065a2c2e66e4e0d24a13bb61f893caa83e03ddc56f8e","tierARecordSha256":"3a00bee275bb5107c1a325ac760d2d554374f0c15cc1c22e46bfd86b5df00618"},"integrity":{"algorithm":"sha256","contentSha256":"37f76a9977623a9b20f5a0a9eb887264d00202a1fd4233fa4eb4e1e0ff890555"}},"pubmed-pmid-17929329-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17929329-lanreotide:v1","objectPathId":"pubmed-pmid-17929329-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17929329-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-17929329-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-17929329-lanreotide-v1"},"story":{"slug":"pubmed-pmid-17929329-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Self-assembly of the octapeptide lanreotide and lanreotide-based derivatives: the role of the aromatic residues.","sourceIds":["pubmed-observation-pmid-17929329-2016-11-24-5a8e6635b4fc"]},{"id":"summary","text":"PubMed lists PMID 17929329 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17929329-2016-11-24-5a8e6635b4fc"]},{"id":"paragraph-1","text":"PubMed lists PMID 17929329 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17929329-2016-11-24-5a8e6635b4fc"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17929329-2016-11-24-5a8e6635b4fc"]}],"sources":[{"id":"pubmed-observation-pmid-17929329-2016-11-24-5a8e6635b4fc","name":"PubMed","sourceClass":"A","title":"Self-assembly of the octapeptide lanreotide and lanreotide-based derivatives: the role of the aromatic residues. · retained source version 1:2016-11-24:current:5a8e6635b4fc6de6d93dfa013308136a7a3ec12c729fe7071c4666d40bbc6d72","url":"https://pubmed.ncbi.nlm.nih.gov/17929329/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f6ac46f6e036777b1fab189db5b690abbaeec3be6a96045e42b8f5662e2c150e","tierARecordSha256":"9bf89f5e99052473b1cce91d4435e2195c7570e5a5e91bddecd798c677745618"},"integrity":{"algorithm":"sha256","contentSha256":"6075b5436a86a148c0c425b68973e8ef5cde10ea6e91b8ac49636a30d7391677"}},"pubmed-pmid-17984236-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17984236-lanreotide:v1","objectPathId":"pubmed-pmid-17984236-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17984236-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-17984236-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-17984236-lanreotide-v1"},"story":{"slug":"pubmed-pmid-17984236-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Optimalization and cost management of lanreotide-Autogel therapy in acromegaly.","sourceIds":["pubmed-observation-pmid-17984236-2016-11-24-635b9cdf9cc1"]},{"id":"summary","text":"PubMed lists PMID 17984236 in European journal of endocrinology as Comparative Study, Journal Article, Multicenter Study, with publication-date metadata of 2007-11 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17984236-2016-11-24-635b9cdf9cc1"]},{"id":"paragraph-1","text":"PubMed lists PMID 17984236 in European journal of endocrinology as Comparative Study, Journal Article, Multicenter Study, with publication-date metadata of 2007-11 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17984236-2016-11-24-635b9cdf9cc1"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17984236-2016-11-24-635b9cdf9cc1"]}],"sources":[{"id":"pubmed-observation-pmid-17984236-2016-11-24-635b9cdf9cc1","name":"PubMed","sourceClass":"A","title":"Optimalization and cost management of lanreotide-Autogel therapy in acromegaly. · retained source version 1:2016-11-24:current:635b9cdf9cc133e7bc7ea8702d983def1a91d3e44fcde7fdfc4ee6025676ba6f","url":"https://pubmed.ncbi.nlm.nih.gov/17984236/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1b0a8a0127cbb734eb0984c5dafedfd59d5cb38e95ae7b41377701e6f4a98bd1","tierARecordSha256":"fbfdcaeacfb14038e7d6fbf52cb15689920cb6a44aa04c432b7ce22a66da2c30"},"integrity":{"algorithm":"sha256","contentSha256":"416cfbfc66d1bf28b71fdf327e898ed6f5c50f1f73cdc9d105b8104210964956"}},"pubmed-pmid-18063933-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-18063933-lanreotide:v1","objectPathId":"pubmed-pmid-18063933-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-18063933-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-18063933-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-18063933-lanreotide-v1"},"story":{"slug":"pubmed-pmid-18063933-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Lanreotide autogel and insulin sensitivity markers: report of 5 acromegalic patients and literature review.","sourceIds":["pubmed-observation-pmid-18063933-2016-11-24-25dcdf65b49d"]},{"id":"summary","text":"PubMed lists PMID 18063933 in Neuro endocrinology letters as Clinical Trial, Journal Article, Review, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18063933-2016-11-24-25dcdf65b49d"]},{"id":"paragraph-1","text":"PubMed lists PMID 18063933 in Neuro endocrinology letters as Clinical Trial, Journal Article, Review, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18063933-2016-11-24-25dcdf65b49d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-18063933-2016-11-24-25dcdf65b49d"]}],"sources":[{"id":"pubmed-observation-pmid-18063933-2016-11-24-25dcdf65b49d","name":"PubMed","sourceClass":"A","title":"Lanreotide autogel and insulin sensitivity markers: report of 5 acromegalic patients and literature review. · retained source version 1:2016-11-24:current:25dcdf65b49d6893601141749ebc520a4e27307c2134c9abd8dd9fdd766da966","url":"https://pubmed.ncbi.nlm.nih.gov/18063933/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a4cf66d670452f058a51dfa376ed21a0e10f0560df7f68d01903ea1e8ce845c5","tierARecordSha256":"2e34b16d348fadba90c8b36d832c448d038d8194e8f3772ba4f813686acae88c"},"integrity":{"algorithm":"sha256","contentSha256":"21e100fc2bf6f8fc90e81a0250c5c5cf300daa06659c4dad3b12ca7a65d27cec"}},"pubmed-pmid-18367285-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-18367285-lanreotide:v1","objectPathId":"pubmed-pmid-18367285-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-18367285-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-18367285-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-18367285-lanreotide-v1"},"story":{"slug":"pubmed-pmid-18367285-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Lanreotide Autogel for persistent diabetic macular edema.","sourceIds":["pubmed-observation-pmid-18367285-2016-11-24-4f30b93e4eb9"]},{"id":"summary","text":"PubMed lists PMID 18367285 in Diabetes research and clinical practice as Case Reports, Journal Article, with publication-date metadata of 2008-03-26 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18367285-2016-11-24-4f30b93e4eb9"]},{"id":"paragraph-1","text":"PubMed lists PMID 18367285 in Diabetes research and clinical practice as Case Reports, Journal Article, with publication-date metadata of 2008-03-26 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18367285-2016-11-24-4f30b93e4eb9"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-18367285-2016-11-24-4f30b93e4eb9"]}],"sources":[{"id":"pubmed-observation-pmid-18367285-2016-11-24-4f30b93e4eb9","name":"PubMed","sourceClass":"A","title":"Lanreotide Autogel for persistent diabetic macular edema. · retained source version 1:2016-11-24:current:4f30b93e4eb99070c75306400e4ab9a950610c47a7e7be896061dbc9340657c2","url":"https://pubmed.ncbi.nlm.nih.gov/18367285/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"98aa38f9731253373c4528a47486536806fd354a41f24039c1022fe80bab62c8","tierARecordSha256":"9d4a7b1084eb8b886bf6cf076286ec8292dcb5d506097aad46683d8c3874d93c"},"integrity":{"algorithm":"sha256","contentSha256":"3ea7c1b6ee379386df175c5ddfe939787af1185710e127edb4c1f4c5c75b417b"}},"pubmed-pmid-18684551-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-18684551-lanreotide:v1","objectPathId":"pubmed-pmid-18684551-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-18684551-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-18684551-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-18684551-lanreotide-v1"},"story":{"slug":"pubmed-pmid-18684551-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide).","sourceIds":["pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1"]},{"id":"summary","text":"PubMed lists PMID 18684551 in European journal of obstetrics, gynecology, and reproductive biology as Case Reports, Letter, with publication-date metadata of 2008-08-05 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1"]},{"id":"paragraph-1","text":"PubMed lists PMID 18684551 in European journal of obstetrics, gynecology, and reproductive biology as Case Reports, Letter, with publication-date metadata of 2008-08-05 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1"]}],"sources":[{"id":"pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1","name":"PubMed","sourceClass":"A","title":"Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide). · retained source version 1:2016-11-24:current:f00668d1cea11b16c76c7065f9b57f9e57a3ab91ba9651eda1d2ff6fa6219be6","url":"https://pubmed.ncbi.nlm.nih.gov/18684551/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"dfaef6adc1b873951a6d722672e3a309182f7e08c9aee0084e7b0687d77f855c","tierARecordSha256":"a96a2b639bbc51747dc39b22409a8e03651683ad1a5d3dc25855e1e33311dd43"},"integrity":{"algorithm":"sha256","contentSha256":"42a7272a18ec08afdca311675e1eea14136915c170b6ab132e5072dc9746335d"}},"pubmed-pmid-19258715-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19258715-lanreotide:v1","objectPathId":"pubmed-pmid-19258715-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19258715-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-19258715-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-19258715-lanreotide-v1"},"story":{"slug":"pubmed-pmid-19258715-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Long-acting lanreotide in adolescent girls with constitutional tall stature.","sourceIds":["pubmed-observation-pmid-19258715-2016-11-25-31d2a1eebfa9"]},{"id":"summary","text":"PubMed lists PMID 19258715 in Hormone research as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2009-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19258715-2016-11-25-31d2a1eebfa9"]},{"id":"paragraph-1","text":"PubMed lists PMID 19258715 in Hormone research as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2009-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19258715-2016-11-25-31d2a1eebfa9"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19258715-2016-11-25-31d2a1eebfa9"]}],"sources":[{"id":"pubmed-observation-pmid-19258715-2016-11-25-31d2a1eebfa9","name":"PubMed","sourceClass":"A","title":"Long-acting lanreotide in adolescent girls with constitutional tall stature. · retained source version 1:2016-11-25:current:31d2a1eebfa99d0c52a97869cf6d8441594d3841074e3b5a9b720b54b7cc347b","url":"https://pubmed.ncbi.nlm.nih.gov/19258715/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"274f97a5fb71d75e9796d3ab3a42512d28cdfbe9091c8ee56cc7594adb980b86","tierARecordSha256":"218c3ae83a7750835c8dcd0b8724a36f898917b6f06a32053f7ed19083f2909f"},"integrity":{"algorithm":"sha256","contentSha256":"71652fcf3310b082fdbffc64f7a8953e2134ef2d1aded7079e923bbffe3db159"}},"pubmed-pmid-20168286-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20168286-lanreotide:v1","objectPathId":"pubmed-pmid-20168286-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20168286-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-20168286-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-20168286-lanreotide-v1"},"story":{"slug":"pubmed-pmid-20168286-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.","sourceIds":["pubmed-observation-pmid-20168286-2016-11-25-d1ab9efa1869"]},{"id":"summary","text":"PubMed lists PMID 20168286 in The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... as Clinical Trial, Journal Article, with publication-date metadata of 2010-02 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20168286-2016-11-25-d1ab9efa1869"]},{"id":"paragraph-1","text":"PubMed lists PMID 20168286 in The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... as Clinical Trial, Journal Article, with publication-date metadata of 2010-02 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20168286-2016-11-25-d1ab9efa1869"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20168286-2016-11-25-d1ab9efa1869"]}],"sources":[{"id":"pubmed-observation-pmid-20168286-2016-11-25-d1ab9efa1869","name":"PubMed","sourceClass":"A","title":"Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography. · retained source version 1:2016-11-25:current:d1ab9efa1869c48145852bbef1f2dde7fa559213e4a6dcbd278c26e3c2197c94","url":"https://pubmed.ncbi.nlm.nih.gov/20168286/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"cfcb2c3cf75ae7a3bf5fb21f3334b8cc7a90d61fb96fc80ac782ee45f9cb6d81","tierARecordSha256":"a9b76f06a41292e61631ecdaed1e4b198d67164068686f46e27b29697987593b"},"integrity":{"algorithm":"sha256","contentSha256":"ad852929649a33c3ed54d8fbe6af4b170cf87fdbe16457e294808a019e008ed0"}},"pubmed-pmid-20199027-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20199027-lanreotide:v1","objectPathId":"pubmed-pmid-20199027-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20199027-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-20199027-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-20199027-lanreotide-v1"},"story":{"slug":"pubmed-pmid-20199027-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Elucidation of the self-assembly pathway of lanreotide octapeptide into beta-sheet nanotubes: role of two stable intermediates.","sourceIds":["pubmed-observation-pmid-20199027-2016-11-25-204f8be609c7"]},{"id":"summary","text":"PubMed lists PMID 20199027 in Journal of the American Chemical Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03-31 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20199027-2016-11-25-204f8be609c7"]},{"id":"paragraph-1","text":"PubMed lists PMID 20199027 in Journal of the American Chemical Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03-31 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20199027-2016-11-25-204f8be609c7"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20199027-2016-11-25-204f8be609c7"]}],"sources":[{"id":"pubmed-observation-pmid-20199027-2016-11-25-204f8be609c7","name":"PubMed","sourceClass":"A","title":"Elucidation of the self-assembly pathway of lanreotide octapeptide into beta-sheet nanotubes: role of two stable intermediates. · retained source version 1:2016-11-25:current:204f8be609c71c6052ba5d93486cec2bb7cd2ca074b9c2883339a8234b584892","url":"https://pubmed.ncbi.nlm.nih.gov/20199027/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6191bc13623e523404cfc9b765b99483b506fd7e9e866a04280a562e2c36c395","tierARecordSha256":"bd01b2877df8237b7b55ea3e5427b5d053a079ca57ea52680766e8a36215a5c0"},"integrity":{"algorithm":"sha256","contentSha256":"5f29580a46b691a0844869863ad4c219390c4e6bb409b57fbea3401555185850"}},"pubmed-pmid-20604834-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20604834-lanreotide:v1","objectPathId":"pubmed-pmid-20604834-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20604834-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-20604834-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-20604834-lanreotide-v1"},"story":{"slug":"pubmed-pmid-20604834-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.","sourceIds":["pubmed-observation-pmid-20604834-2016-11-25-695da1512200"]},{"id":"summary","text":"PubMed lists PMID 20604834 in The Journal of pharmacy and pharmacology as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20604834-2016-11-25-695da1512200"]},{"id":"paragraph-1","text":"PubMed lists PMID 20604834 in The Journal of pharmacy and pharmacology as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20604834-2016-11-25-695da1512200"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20604834-2016-11-25-695da1512200"]}],"sources":[{"id":"pubmed-observation-pmid-20604834-2016-11-25-695da1512200","name":"PubMed","sourceClass":"A","title":"Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats. · retained source version 1:2016-11-25:current:695da151220066cdbfe3d0b90f22a4c1ea7783871cba56aad6e8c6dcb80f95b1","url":"https://pubmed.ncbi.nlm.nih.gov/20604834/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1dc078bdb9f3ad6285eb9f504d0ede9c7630c1797b4846bb4616f23ed43daee1","tierARecordSha256":"b0fd63b055e1030b684f1d8822b06640d88c8335c2b06bf1c513c11924733379"},"integrity":{"algorithm":"sha256","contentSha256":"b52b7c2e734a63cf011e3268e3a31c9648b1c06284fdd2b3dabffaa3682caa5d"}},"pubmed-pmid-21135689-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-21135689-lanreotide:v1","objectPathId":"pubmed-pmid-21135689-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-21135689-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-21135689-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-21135689-lanreotide-v1"},"story":{"slug":"pubmed-pmid-21135689-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Use of lanreotide for the treatment of gastrointestinal fistulae.","sourceIds":["pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387"]},{"id":"summary","text":"PubMed lists PMID 21135689 in Annals of surgery as Letter, Comment, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387"]},{"id":"paragraph-1","text":"PubMed lists PMID 21135689 in Annals of surgery as Letter, Comment, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387"]}],"sources":[{"id":"pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387","name":"PubMed","sourceClass":"A","title":"Use of lanreotide for the treatment of gastrointestinal fistulae. · retained source version 1:2016-11-25:current:1cfb22a9d3870b7e907b6c3480a09dd7e6742cf8575e41228be2f61f4790dd9c","url":"https://pubmed.ncbi.nlm.nih.gov/21135689/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"eb0a179d14fa62b32a84736b81e1300ad64391ccde5068679f04ca64f418d8e0","tierARecordSha256":"2249ec22ba0aa2c823d424af1c546316947a9aa7f9b058645e5072d9d331cc48"},"integrity":{"algorithm":"sha256","contentSha256":"d24f1ae9bf69e72785180c6ceb7e233300c1151c4494a1343765467b9e730992"}},"pubmed-pmid-21607321-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-21607321-lanreotide:v1","objectPathId":"pubmed-pmid-21607321-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-21607321-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-21607321-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-21607321-lanreotide-v1"},"story":{"slug":"pubmed-pmid-21607321-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2011-05-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-10","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 21607321","sourceIds":["pubmed-observation-pmid-21607321-2011-05-24-2eb5bea25f63"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 21607321 at 2026-07-30T22:17:00.088Z. PubMed recorded a metadata revision date of 2011-05-24 and an Entrez history date of 2011-05-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-21607321-2011-05-24-2eb5bea25f63"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 21607321 at 2026-07-30T22:17:00.088Z. PubMed recorded a metadata revision date of 2011-05-24 and an Entrez history date of 2011-05-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-21607321-2011-05-24-2eb5bea25f63"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-21607321-2011-05-24-2eb5bea25f63"]}],"sources":[{"id":"pubmed-observation-pmid-21607321-2011-05-24-2eb5bea25f63","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 21607321 · retained source version 1:2011-05-24:current:2eb5bea25f637392910c1ceee3a2a8c6ccfac922a789fc8d83ccc9296fd58a45","url":"https://pubmed.ncbi.nlm.nih.gov/21607321/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"376e37514a3912d6f72136496d37eca147ad6fad105025c251a766080920335e","tierARecordSha256":"5c40a79200b9690e139a1cbf113b3119d3e2a5c2a32990ecf722c8cc63c911a7"},"integrity":{"algorithm":"sha256","contentSha256":"5135c29d97a163780f4cab9f18be6b1d9260f76e454de03447206634ddb4dfb5"}},"pubmed-pmid-25682623-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-25682623-lanreotide:v1","objectPathId":"pubmed-pmid-25682623-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-25682623-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-25682623-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-25682623-lanreotide-v1"},"story":{"slug":"pubmed-pmid-25682623-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Resolving bile reflux by lanreotide in patients with Roux-en-Y gastrojejunostomy.","sourceIds":["pubmed-observation-pmid-25682623-2016-11-25-3b8876273c12"]},{"id":"summary","text":"PubMed lists PMID 25682623 in Acta gastro-enterologica Belgica as Case Reports, Journal Article, with publication-date metadata of 2014-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25682623-2016-11-25-3b8876273c12"]},{"id":"paragraph-1","text":"PubMed lists PMID 25682623 in Acta gastro-enterologica Belgica as Case Reports, Journal Article, with publication-date metadata of 2014-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25682623-2016-11-25-3b8876273c12"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-25682623-2016-11-25-3b8876273c12"]}],"sources":[{"id":"pubmed-observation-pmid-25682623-2016-11-25-3b8876273c12","name":"PubMed","sourceClass":"A","title":"Resolving bile reflux by lanreotide in patients with Roux-en-Y gastrojejunostomy. · retained source version 1:2016-11-25:current:3b8876273c12a6d08cc0986b7b690557871d063c3aef043e774b3fd53362c4d3","url":"https://pubmed.ncbi.nlm.nih.gov/25682623/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d98e294ffcc27ab4854e48487763e08b410cc0aa2d6cb194db7ab8e943451347","tierARecordSha256":"4f4876f85dd94cc84ad0b2938a445fe2a61a74d8b39977a175ce59d0b0862895"},"integrity":{"algorithm":"sha256","contentSha256":"4cd8f191587e12285dc18b384dc4e1afae92b660565c14bf6b93fb515bd3e05e"}},"pubmed-pmid-25746137-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-25746137-lanreotide:v1","objectPathId":"pubmed-pmid-25746137-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-25746137-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-25746137-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-25746137-lanreotide-v1"},"story":{"slug":"pubmed-pmid-25746137-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.","sourceIds":["pubmed-observation-pmid-25746137-2016-11-25-dc806b43134c"]},{"id":"summary","text":"PubMed lists PMID 25746137 in Clinics and research in hepatology and gastroenterology as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25746137-2016-11-25-dc806b43134c"]},{"id":"paragraph-1","text":"PubMed lists PMID 25746137 in Clinics and research in hepatology and gastroenterology as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25746137-2016-11-25-dc806b43134c"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-25746137-2016-11-25-dc806b43134c"]}],"sources":[{"id":"pubmed-observation-pmid-25746137-2016-11-25-dc806b43134c","name":"PubMed","sourceClass":"A","title":"Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma. · retained source version 1:2016-11-25:current:dc806b43134ceedf35151775ed56fb728d132411edb1e65904dccfdba61d2dff","url":"https://pubmed.ncbi.nlm.nih.gov/25746137/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"63d2a32824faae85d3c9c771c76941d8b0989a17e5ef270dddc15de25508b4ba","tierARecordSha256":"bed93f51eab3ffdddf2605ee5b60f155d33cf6592153478fd4c4cba667ea2808"},"integrity":{"algorithm":"sha256","contentSha256":"a30568ea040f1fbf1ffccb0452c81f758af384463f9b001f7d43feb35ee8932b"}},"pubmed-pmid-27200668-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-27200668-lanreotide:v1","objectPathId":"pubmed-pmid-27200668-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-27200668-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-27200668-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-27200668-lanreotide-v1"},"story":{"slug":"pubmed-pmid-27200668-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-05-21","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-10","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 27200668","sourceIds":["pubmed-observation-pmid-27200668-2016-05-21-b66ad3598663"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 27200668 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-27200668-2016-05-21-b66ad3598663"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 27200668 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-27200668-2016-05-21-b66ad3598663"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-27200668-2016-05-21-b66ad3598663"]}],"sources":[{"id":"pubmed-observation-pmid-27200668-2016-05-21-b66ad3598663","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 27200668 · retained source version 1:2016-05-21:current:b66ad359866312b381f1d0b589ef3983a83aa82caf8c9500dbaec1c06a0ed3af","url":"https://pubmed.ncbi.nlm.nih.gov/27200668/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8243b76be7426dad141b9cda6dce8e25e7b0ed3830ad9b13fe4fb49432f17cd9","tierARecordSha256":"33ff900edec4dbb8e552548927793c3222c94c1b4c7a74be37b67dcdc0553c6d"},"integrity":{"algorithm":"sha256","contentSha256":"1614c605395705888e9153f43dbdd0f1f27cb873dd12c88b6488a6361d0d34d2"}},"pubmed-pmid-38071418-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38071418-lanreotide:v1","objectPathId":"pubmed-pmid-38071418-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38071418-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-38071418-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-38071418-lanreotide-v1"},"story":{"slug":"pubmed-pmid-38071418-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-05-18","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 38071418","sourceIds":["pubmed-observation-pmid-38071418-2026-05-18-74e17d2115b4"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 38071418 at 2026-07-30T16:20:36.586Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2023-12-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-38071418-2026-05-18-74e17d2115b4"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 38071418 at 2026-07-30T16:20:36.586Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2023-12-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-38071418-2026-05-18-74e17d2115b4"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38071418-2026-05-18-74e17d2115b4"]}],"sources":[{"id":"pubmed-observation-pmid-38071418-2026-05-18-74e17d2115b4","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 38071418 · retained source version 1:2026-05-18:current:74e17d2115b41b266d6c32bc6d9cb69b6f68a0a411567765a2626efe1fd0d05f","url":"https://pubmed.ncbi.nlm.nih.gov/38071418/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d20e29b664e8d346472cd15ec222c80b40e423fb40c25b2e07a2d0ea0319bf02","tierARecordSha256":"d2ec688d4276e2da6a99b464101b60e2021ad61257bad80cc8cdbd8902a2f1ea"},"integrity":{"algorithm":"sha256","contentSha256":"82b8817a789c751337277aef4f941b53825dbe889792e9d86593565e6f4eee01"}},"pubmed-pmid-38206830-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38206830-lanreotide:v1","objectPathId":"pubmed-pmid-38206830-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38206830-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-38206830-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-38206830-lanreotide-v1"},"story":{"slug":"pubmed-pmid-38206830-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-04-30","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.","sourceIds":["pubmed-observation-pmid-38206830-2026-04-30-9a3b7f34f72a"]},{"id":"summary","text":"PubMed lists PMID 38206830 in The oncologist as Journal Article, Clinical Trial, Phase II, Research Support, Non-U.S. Gov't, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-05-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38206830-2026-04-30-9a3b7f34f72a"]},{"id":"paragraph-1","text":"PubMed lists PMID 38206830 in The oncologist as Journal Article, Clinical Trial, Phase II, Research Support, Non-U.S. Gov't, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-05-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38206830-2026-04-30-9a3b7f34f72a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38206830-2026-04-30-9a3b7f34f72a"]}],"sources":[{"id":"pubmed-observation-pmid-38206830-2026-04-30-9a3b7f34f72a","name":"PubMed","sourceClass":"A","title":"Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study. · retained source version 1:2026-04-30:current:9a3b7f34f72ae55a13b9d614daf28e593d472ad01713bf8234b958ee2d57ad5d","url":"https://pubmed.ncbi.nlm.nih.gov/38206830/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5b72059bbae724aec7af829bbe10e4e65f334771c455c6bfad420f86caa47f85","tierARecordSha256":"a258a95fd09e55426856c60a321bdbbfec25cc727d572273b0aee09660664a92"},"integrity":{"algorithm":"sha256","contentSha256":"63ba7cfc07091c3d999640bf70cea20cc2525a6314162556ceff4148b5f03359"}},"pubmed-pmid-39491674-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-39491674-lanreotide:v1","objectPathId":"pubmed-pmid-39491674-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-39491674-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-39491674-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-39491674-lanreotide-v1"},"story":{"slug":"pubmed-pmid-39491674-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-05-17","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"β-Cyclodextrin derivatives bind aromatic side chains of the cyclic peptide lanreotide.","sourceIds":["pubmed-observation-pmid-39491674-2026-05-17-2f1f823680fc"]},{"id":"summary","text":"PubMed lists PMID 39491674 in Journal of pharmaceutical sciences as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-11-02 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39491674-2026-05-17-2f1f823680fc"]},{"id":"paragraph-1","text":"PubMed lists PMID 39491674 in Journal of pharmaceutical sciences as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-11-02 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-39491674-2026-05-17-2f1f823680fc"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-39491674-2026-05-17-2f1f823680fc"]}],"sources":[{"id":"pubmed-observation-pmid-39491674-2026-05-17-2f1f823680fc","name":"PubMed","sourceClass":"A","title":"β-Cyclodextrin derivatives bind aromatic side chains of the cyclic peptide lanreotide. · retained source version 1:2026-05-17:current:2f1f823680fcb8de0f2d773287c3601a31267253146e281c68f7ccfde6c15a00","url":"https://pubmed.ncbi.nlm.nih.gov/39491674/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ed71f15fd6cadcdd53e2b7b2a9a2a1f427072b7daba99a7a5ec5f9185c5ef0b1","tierARecordSha256":"0eb64939b7fca14270723b27c7171dac90a79cb4020f42b31e581d5895140cf9"},"integrity":{"algorithm":"sha256","contentSha256":"8a694417089e35a2306c23cbb20066dd714d291e21fbbccb62f5c12213971f74"}},"pubmed-pmid-39933708-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-39933708-lanreotide:v1","objectPathId":"pubmed-pmid-39933708-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-39933708-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-39933708-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-39933708-lanreotide-v1"},"story":{"slug":"pubmed-pmid-39933708-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-06-09","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 39933708","sourceIds":["pubmed-observation-pmid-39933708-2026-06-09-66fec74eaed4"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 39933708 at 2026-07-30T16:14:10.854Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-02-11. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-39933708-2026-06-09-66fec74eaed4"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 39933708 at 2026-07-30T16:14:10.854Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-02-11. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-39933708-2026-06-09-66fec74eaed4"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-39933708-2026-06-09-66fec74eaed4"]}],"sources":[{"id":"pubmed-observation-pmid-39933708-2026-06-09-66fec74eaed4","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 39933708 · retained source version 1:2026-06-09:current:66fec74eaed402b22faffb8054f34d32687fb7c06e3febc03651189e55d4aa88","url":"https://pubmed.ncbi.nlm.nih.gov/39933708/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5e81d3049a544117b5383edef53c2a66bc9227c16de842569a1b91695a1d39b2","tierARecordSha256":"be580ce00d57eb6c73869920b1dfe7afdc3cdd87dc6944b173fb30f7b942af9c"},"integrity":{"algorithm":"sha256","contentSha256":"273dbb299084238f7740ae1d638ff7857babd9a6a26da44b8bc2474903308796"}},"pubmed-pmid-41071230-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41071230-lanreotide:v1","objectPathId":"pubmed-pmid-41071230-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41071230-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-41071230-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-41071230-lanreotide-v1"},"story":{"slug":"pubmed-pmid-41071230-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-03-25","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Lanreotide in endothelial corneal inflammation.","sourceIds":["pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb"]},{"id":"summary","text":"PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb"]},{"id":"paragraph-1","text":"PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb"]}],"sources":[{"id":"pubmed-observation-pmid-41071230-2026-03-25-a4ce3d1a2dbb","name":"PubMed","sourceClass":"A","title":"Lanreotide in endothelial corneal inflammation. · retained source version 1:2026-03-25:current:a4ce3d1a2dbbb3d55f7922623629a063ca8894c59c34cdb0e9d9cc10d4ede6bd","url":"https://pubmed.ncbi.nlm.nih.gov/41071230/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"45747e52cd1fc140621c7238716f53c345ade566cb4948d92c4fa238181b6ce1","tierARecordSha256":"f3938e19a5c511f4a984f09e9496eb0b05bc24c719a2c1a7438489007c25469e"},"integrity":{"algorithm":"sha256","contentSha256":"5a070841444d7f3bf8a2dbf8d6227fb3d6455b0b9d2d8770a9c620a0037a76ce"}},"pubmed-pmid-41880072-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41880072-lanreotide:v1","objectPathId":"pubmed-pmid-41880072-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41880072-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-41880072-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-41880072-lanreotide-v1"},"story":{"slug":"pubmed-pmid-41880072-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-06-27","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 41880072","sourceIds":["pubmed-observation-pmid-41880072-2026-06-27-12975518d046"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41880072 at 2026-07-30T16:14:14.928Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-03-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41880072-2026-06-27-12975518d046"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 41880072 at 2026-07-30T16:14:14.928Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-03-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-41880072-2026-06-27-12975518d046"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41880072-2026-06-27-12975518d046"]}],"sources":[{"id":"pubmed-observation-pmid-41880072-2026-06-27-12975518d046","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 41880072 · retained source version 1:2026-06-27:current:12975518d046b255d866948fba51a8c0e50030f7230515c78a2afc4b58997435","url":"https://pubmed.ncbi.nlm.nih.gov/41880072/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"be84d7dda22e28689e43a62a0694faaa90029d6206ce3c57c0fe48a77ca501b8","tierARecordSha256":"09eb044fc422f05aa17858f4754e232a9f03a4ec036cea618862b217fda35ad9"},"integrity":{"algorithm":"sha256","contentSha256":"795ffd0cf18c3324d4ef5bf3b9898aef2c135c84009656bc04e530fe3cfbeb72"}},"pubmed-pmid-42721062-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42721062-lanreotide:v1","objectPathId":"pubmed-pmid-42721062-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42721062-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-42721062-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-42721062-lanreotide-v1"},"story":{"slug":"pubmed-pmid-42721062-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-09-21","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.","sourceIds":["pubmed-observation-pmid-42721062-2026-09-21-5b1b4aab5391"]},{"id":"summary","text":"PubMed lists PMID 42721062 in Archives of endocrinology and metabolism as Case Reports, Journal Article, with publication-date metadata of 2026-09-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42721062-2026-09-21-5b1b4aab5391"]},{"id":"paragraph-1","text":"PubMed lists PMID 42721062 in Archives of endocrinology and metabolism as Case Reports, Journal Article, with publication-date metadata of 2026-09-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42721062-2026-09-21-5b1b4aab5391"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42721062-2026-09-21-5b1b4aab5391"]}],"sources":[{"id":"pubmed-observation-pmid-42721062-2026-09-21-5b1b4aab5391","name":"PubMed","sourceClass":"A","title":"Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy. · retained source version 1:2026-09-21:current:5b1b4aab539131c0db64d6d2f18a0e26c44a3a3e5d995e1a898fd8f8c53b4bdd","url":"https://pubmed.ncbi.nlm.nih.gov/42721062/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"bbe85ea452b67d20cc7c6999eac50596950f5fdf3fadc384934ea9d647d63bf3","tierARecordSha256":"0b94eab4fcfee9448eb79b45641292974a51ee8d7720aa70907ec7adf7034d7f"},"integrity":{"algorithm":"sha256","contentSha256":"2bed81cac80620fc6d02a03f875aaaaec12b39938417845f1d44ef8afd5ab265"}},"pubmed-pmid-42791653-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42791653-lanreotide:v1","objectPathId":"pubmed-pmid-42791653-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42791653-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-42791653-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-42791653-lanreotide-v1"},"story":{"slug":"pubmed-pmid-42791653-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-09-30","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.","sourceIds":["pubmed-observation-pmid-42791653-2026-09-30-720ad5b64a72"]},{"id":"summary","text":"PubMed lists PMID 42791653 in Cancer medicine as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2026-10 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42791653-2026-09-30-720ad5b64a72"]},{"id":"paragraph-1","text":"PubMed lists PMID 42791653 in Cancer medicine as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2026-10 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42791653-2026-09-30-720ad5b64a72"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42791653-2026-09-30-720ad5b64a72"]}],"sources":[{"id":"pubmed-observation-pmid-42791653-2026-09-30-720ad5b64a72","name":"PubMed","sourceClass":"A","title":"Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study. · retained source version 1:2026-09-30:current:720ad5b64a72166abf418e1673c8df3f76a1b3c37ba488c6d1d3d1ff1acda781","url":"https://pubmed.ncbi.nlm.nih.gov/42791653/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"26aa5fee695f4fce043e8b407d30732224171097d0a2d12273643f8d04270b9f","tierARecordSha256":"3e1bbf24376cd3c9ee37276111daf6407c3074a01f7cccc9c8603e2263f40096"},"integrity":{"algorithm":"sha256","contentSha256":"942f202901b1f488903efebfc398c444f389c8f6635969b69a8bfb5129c6f4b3"}},"pubmed-pmid-42976416-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42976416-lanreotide:v1","objectPathId":"pubmed-pmid-42976416-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42976416-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-42976416-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-42976416-lanreotide-v1"},"story":{"slug":"pubmed-pmid-42976416-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2026-11-13","sourceCheckedAt":"2026-11-14","publishedAt":"2026-11-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study.","sourceIds":["pubmed-observation-pmid-42976416-2026-11-13-3af6ea5f41c6"]},{"id":"summary","text":"PubMed lists PMID 42976416 in ESMO open as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42976416-2026-11-13-3af6ea5f41c6"]},{"id":"paragraph-1","text":"PubMed lists PMID 42976416 in ESMO open as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42976416-2026-11-13-3af6ea5f41c6"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42976416-2026-11-13-3af6ea5f41c6"]}],"sources":[{"id":"pubmed-observation-pmid-42976416-2026-11-13-3af6ea5f41c6","name":"PubMed","sourceClass":"A","title":"A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study. · retained source version 1:2026-11-13:current:3af6ea5f41c67c1e8d84ce6ffc9fd67581d1248af12a09609544317f300deb90","url":"https://pubmed.ncbi.nlm.nih.gov/42976416/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3c80f335c99a3871f2a4f6120df918e33015b026e166cc976f4da90d1973e5ee","tierARecordSha256":"5f78547a341e41d24e0d9edca57918b96c42bd5247e6363fb260ebe7688f62a7"},"integrity":{"algorithm":"sha256","contentSha256":"709560d6d4c211f14a192764612212d368a46a188729e2c0f5f4cd0ce4d14d9e"}},"pubmed-pmid-7540120-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-7540120-lanreotide:v1","objectPathId":"pubmed-pmid-7540120-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-7540120-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-7540120-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-7540120-lanreotide-v1"},"story":{"slug":"pubmed-pmid-7540120-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-23","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-10","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 7540120","sourceIds":["pubmed-observation-pmid-7540120-2016-11-23-33b5ce2cd1ac"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 7540120 at 2026-07-30T21:35:51.187Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-7540120-2016-11-23-33b5ce2cd1ac"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 7540120 at 2026-07-30T21:35:51.187Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-7540120-2016-11-23-33b5ce2cd1ac"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-7540120-2016-11-23-33b5ce2cd1ac"]}],"sources":[{"id":"pubmed-observation-pmid-7540120-2016-11-23-33b5ce2cd1ac","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 7540120 · retained source version 1:2016-11-23:current:33b5ce2cd1ac45ab952e41b40eb8db052e6a80fc7c9a7a728878cf87d07fc288","url":"https://pubmed.ncbi.nlm.nih.gov/7540120/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"93e07186daf76795a158aa2c377faa3348bc84569080dadf9a3f4bf30df361a3","tierARecordSha256":"314cb7cefbb607e98606e0be67015febef9ce86bcded5a6ce43ea49df3356e80"},"integrity":{"algorithm":"sha256","contentSha256":"9ad9d9b67f4a955f799f77104fbbaefa9814bcc13a93d01f8c04cb241dcded5d"}},"pubmed-pmid-7864583-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-7864583-lanreotide:v1","objectPathId":"pubmed-pmid-7864583-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-7864583-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-7864583-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-7864583-lanreotide-v1"},"story":{"slug":"pubmed-pmid-7864583-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-23","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-11","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 7864583","sourceIds":["pubmed-observation-pmid-7864583-2016-11-23-59d379984a4a"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 7864583 at 2026-07-30T21:35:51.193Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1994-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-7864583-2016-11-23-59d379984a4a"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 7864583 at 2026-07-30T21:35:51.193Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1994-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-7864583-2016-11-23-59d379984a4a"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-7864583-2016-11-23-59d379984a4a"]}],"sources":[{"id":"pubmed-observation-pmid-7864583-2016-11-23-59d379984a4a","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 7864583 · retained source version 1:2016-11-23:current:59d379984a4a9169346a9b665c3bb0befba80e32ce8821c86f9706f093838be6","url":"https://pubmed.ncbi.nlm.nih.gov/7864583/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"354cc2b14f55e846ac4949eac7b3e2d2fb2bc982ce5c2f2c018f7a7c5c12154e","tierARecordSha256":"b0ba48a63228f34f922e480d987a5a23e2a112830c54c6b0adffd2de103d4d8a"},"integrity":{"algorithm":"sha256","contentSha256":"9460016831b599718b8ae817199e216a266db5f97118ef87c42ae69d4d8cc085"}},"pubmed-pmid-8099735-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-8099735-lanreotide:v1","objectPathId":"pubmed-pmid-8099735-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-8099735-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-8099735-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-8099735-lanreotide-v1"},"story":{"slug":"pubmed-pmid-8099735-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-12-09","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-14","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog].","sourceIds":["pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38"]},{"id":"summary","text":"PubMed lists PMID 8099735 in Presse medicale (Paris, France : 1983) as Journal Article, with publication-date metadata of 1993-03-27 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38"]},{"id":"paragraph-1","text":"PubMed lists PMID 8099735 in Presse medicale (Paris, France : 1983) as Journal Article, with publication-date metadata of 1993-03-27 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38"]}],"sources":[{"id":"pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38","name":"PubMed","sourceClass":"A","title":"[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog]. · retained source version 1:2016-12-09:current:c79dc4a68c382253ef4da8fcee618d6ad13bb2dabb894870643120d36a3f21e6","url":"https://pubmed.ncbi.nlm.nih.gov/8099735/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"09c44155f81599505d2328821e31b83a536e8e285eee2c126acfb70af4932dd3","tierARecordSha256":"ec29a703d348857f4c32952a3d0b50dd7901efc6f604d1103af50bb26ac87e23"},"integrity":{"algorithm":"sha256","contentSha256":"db9f5d01a6cd8bfb18bc65325163fff07bc7261087abe8f47cfee7474d91f217"}},"pubmed-pmid-8646723-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-8646723-lanreotide:v1","objectPathId":"pubmed-pmid-8646723-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-8646723-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-8646723-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-8646723-lanreotide-v1"},"story":{"slug":"pubmed-pmid-8646723-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-23","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-11","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 8646723","sourceIds":["pubmed-observation-pmid-8646723-2016-11-23-d37fa2753d58"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8646723 at 2026-07-30T21:35:51.201Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-07-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8646723-2016-11-23-d37fa2753d58"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8646723 at 2026-07-30T21:35:51.201Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-07-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8646723-2016-11-23-d37fa2753d58"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-8646723-2016-11-23-d37fa2753d58"]}],"sources":[{"id":"pubmed-observation-pmid-8646723-2016-11-23-d37fa2753d58","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 8646723 · retained source version 1:2016-11-23:current:d37fa2753d58439ce4776bb9b1276b9c3f90900f1587cb130fa2885721aba88c","url":"https://pubmed.ncbi.nlm.nih.gov/8646723/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b128734bdf4e029ecfa61b7964862ea64922de6be6810c9080a754e5f49e0ff4","tierARecordSha256":"d93356a46ac238568bbd531fe4f885a3907c80a95fc3cbe452053d77edaac3af"},"integrity":{"algorithm":"sha256","contentSha256":"63e1aad831bbec3d2ac149d39a78d9f13961d2a626a1ce5cc5ccf647cd9c6553"}},"pubmed-pmid-8786564-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-8786564-lanreotide:v1","objectPathId":"pubmed-pmid-8786564-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-8786564-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-8786564-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-8786564-lanreotide-v1"},"story":{"slug":"pubmed-pmid-8786564-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-23","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-11","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 8786564","sourceIds":["pubmed-observation-pmid-8786564-2016-11-23-6ce4b4c72697"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8786564 at 2026-07-30T21:35:51.203Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-03-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8786564-2016-11-23-6ce4b4c72697"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8786564 at 2026-07-30T21:35:51.203Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-03-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8786564-2016-11-23-6ce4b4c72697"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-8786564-2016-11-23-6ce4b4c72697"]}],"sources":[{"id":"pubmed-observation-pmid-8786564-2016-11-23-6ce4b4c72697","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 8786564 · retained source version 1:2016-11-23:current:6ce4b4c726972468e9b6d739917cbbc3352f1bea0ddcf89788e67ebb39ee9a75","url":"https://pubmed.ncbi.nlm.nih.gov/8786564/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7e6f698ee2ff8002af0eb54e23c75a6e0027465bc731ea3eb2eb6ca5d823d6ca","tierARecordSha256":"d52baf5bc2e523ed637479bf83bf52243017c432d5e9ca2155ff81356e08f4ae"},"integrity":{"algorithm":"sha256","contentSha256":"3ee1a5b1070a343847c4da93fbb3272cf9a4fc5fb42e0a65152f1985088a401c"}},"pubmed-pmid-8813476-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-8813476-lanreotide:v1","objectPathId":"pubmed-pmid-8813476-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-8813476-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-8813476-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-8813476-lanreotide-v1"},"story":{"slug":"pubmed-pmid-8813476-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2018-02-16","sourceCheckedAt":"2026-07-30","publishedAt":"2026-09-09","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours.","sourceIds":["pubmed-observation-pmid-8813476-2018-02-16-d4200e746a01"]},{"id":"summary","text":"PubMed lists PMID 8813476 in Digestion as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 1996 (year precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-8813476-2018-02-16-d4200e746a01"]},{"id":"paragraph-1","text":"PubMed lists PMID 8813476 in Digestion as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 1996 (year precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-8813476-2018-02-16-d4200e746a01"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-8813476-2018-02-16-d4200e746a01"]}],"sources":[{"id":"pubmed-observation-pmid-8813476-2018-02-16-d4200e746a01","name":"PubMed","sourceClass":"A","title":"The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours. · retained source version 1:2018-02-16:current:d4200e746a01c9a70fd14d7e9637543607bf5159be679c4e6c89ac3de5cc165a","url":"https://pubmed.ncbi.nlm.nih.gov/8813476/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5bbd4aad63ab70cb08c704e2268a963d6423f7965831c2b51b69fdafdc80b810","tierARecordSha256":"0a81ee7f6b5ab4e0c509d0f4465ea60d4d68eb494db7027ca8e3816e2039b3bb"},"integrity":{"algorithm":"sha256","contentSha256":"ff1712b48b6e7fd12aac559dd9f987d4a2cf324b904518f836be58c04adc6877"}},"pubmed-pmid-8931985-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-8931985-lanreotide:v1","objectPathId":"pubmed-pmid-8931985-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-8931985-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-8931985-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-8931985-lanreotide-v1"},"story":{"slug":"pubmed-pmid-8931985-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-23","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-11","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 8931985","sourceIds":["pubmed-observation-pmid-8931985-2016-11-23-cb461cfd4edb"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8931985 at 2026-07-30T21:35:51.205Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8931985-2016-11-23-cb461cfd4edb"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8931985 at 2026-07-30T21:35:51.205Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8931985-2016-11-23-cb461cfd4edb"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-8931985-2016-11-23-cb461cfd4edb"]}],"sources":[{"id":"pubmed-observation-pmid-8931985-2016-11-23-cb461cfd4edb","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 8931985 · retained source version 1:2016-11-23:current:cb461cfd4edbf5165b18a8d89db3f21424c750b0573db1061963da630966596d","url":"https://pubmed.ncbi.nlm.nih.gov/8931985/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4cdca3cde5d46867e79e0f8183035397d0dbe9675435ac782018ec3aa07adde5","tierARecordSha256":"e6fc7cc2867716f76a27f19ab3858d2617bd841853fe276aacb745402916d5db"},"integrity":{"algorithm":"sha256","contentSha256":"e24d0b97b638cf03e056acd65919a0490267a3f579a5813b2edc97bb917dce1a"}},"pubmed-pmid-8954072-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-8954072-lanreotide:v1","objectPathId":"pubmed-pmid-8954072-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-8954072-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-8954072-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-8954072-lanreotide-v1"},"story":{"slug":"pubmed-pmid-8954072-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 8954072","sourceIds":["pubmed-observation-pmid-8954072-2016-11-24-66379f26b2de"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8954072 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8954072-2016-11-24-66379f26b2de"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8954072 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8954072-2016-11-24-66379f26b2de"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-8954072-2016-11-24-66379f26b2de"]}],"sources":[{"id":"pubmed-observation-pmid-8954072-2016-11-24-66379f26b2de","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 8954072 · retained source version 1:2016-11-24:current:66379f26b2de6b313d85496538a6e6cc72d9005b3d83f23ff0bc286aae3097ab","url":"https://pubmed.ncbi.nlm.nih.gov/8954072/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"105d4f9a60967da52a9fde9ee1eea3a20923d9b0c8b30f560d6142165a2ed065","tierARecordSha256":"ab6fc069a4665adda51807dadf7222f914587bb4e5cb2233085c2cb92e5fccca"},"integrity":{"algorithm":"sha256","contentSha256":"5fe36c59a6c39d0d64e8142e232cd48c3bbff2efeace467b01425a42ebde70c1"}},"pubmed-pmid-8975096-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-8975096-lanreotide:v1","objectPathId":"pubmed-pmid-8975096-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-8975096-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-8975096-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-8975096-lanreotide-v1"},"story":{"slug":"pubmed-pmid-8975096-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-23","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 8975096","sourceIds":["pubmed-observation-pmid-8975096-2016-11-23-a413a953942b"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8975096 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8975096-2016-11-23-a413a953942b"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 8975096 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-8975096-2016-11-23-a413a953942b"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-8975096-2016-11-23-a413a953942b"]}],"sources":[{"id":"pubmed-observation-pmid-8975096-2016-11-23-a413a953942b","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 8975096 · retained source version 1:2016-11-23:current:a413a953942b1bf55943dbd43cbc090d7acea438f3916ffc0c97c182e3bd22ae","url":"https://pubmed.ncbi.nlm.nih.gov/8975096/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d976d190109ccea2645d93afabcc7327b81ab0398498634590ff48e248df1161","tierARecordSha256":"7a00a152cef16d6069ee9a9fa1d3d4a861104531a35e8d7fa2041dbc585dfc20"},"integrity":{"algorithm":"sha256","contentSha256":"491ebf672cabaf1eb5d63389bbf9d257b1576b48f20029e7d543526428e62f64"}},"pubmed-pmid-9119171-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-9119171-lanreotide:v1","objectPathId":"pubmed-pmid-9119171-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-9119171-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-9119171-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-9119171-lanreotide-v1"},"story":{"slug":"pubmed-pmid-9119171-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 9119171","sourceIds":["pubmed-observation-pmid-9119171-2016-11-24-9568ef762c12"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9119171 at 2026-07-30T21:35:52.319Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9119171-2016-11-24-9568ef762c12"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9119171 at 2026-07-30T21:35:52.319Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9119171-2016-11-24-9568ef762c12"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-9119171-2016-11-24-9568ef762c12"]}],"sources":[{"id":"pubmed-observation-pmid-9119171-2016-11-24-9568ef762c12","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 9119171 · retained source version 1:2016-11-24:current:9568ef762c121f4150cf6b754c5bd6d327c06183f326b9420f01e0731ad224c6","url":"https://pubmed.ncbi.nlm.nih.gov/9119171/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3e226cd29ab83b519170f1d8ffea2a8ae3da668a5319ac556b65085d17bb8912","tierARecordSha256":"09ec05594e968f602f6dad5e3933f7b2cbdd4b1271020d3d7bf50cbc8a3616d5"},"integrity":{"algorithm":"sha256","contentSha256":"2fac83fb23a3d9de4fa3d9ca5aa875bbd10ae81fce8f511673187c468993a03f"}},"pubmed-pmid-9537429-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-9537429-lanreotide:v1","objectPathId":"pubmed-pmid-9537429-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-9537429-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-9537429-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-9537429-lanreotide-v1"},"story":{"slug":"pubmed-pmid-9537429-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 9537429","sourceIds":["pubmed-observation-pmid-9537429-2016-11-24-dd929599971d"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9537429 at 2026-07-30T21:35:52.324Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-04-16. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9537429-2016-11-24-dd929599971d"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9537429 at 2026-07-30T21:35:52.324Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-04-16. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9537429-2016-11-24-dd929599971d"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-9537429-2016-11-24-dd929599971d"]}],"sources":[{"id":"pubmed-observation-pmid-9537429-2016-11-24-dd929599971d","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 9537429 · retained source version 1:2016-11-24:current:dd929599971d3a5a6dd159e2103f7f2c49a7e73cab44ffec4b6589c56f025f20","url":"https://pubmed.ncbi.nlm.nih.gov/9537429/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fa104971284a53b3397cfaa9b380439f9a4c3796c9ed80cfcc4859ed147b8fa8","tierARecordSha256":"1623a07b2ec18c913b062db9781c8d480918abb0385b121ba4f291981c7a6f12"},"integrity":{"algorithm":"sha256","contentSha256":"00c588f521705c1c62d677da17057b658409a0d1057c7107e1f360c2369bfc73"}},"pubmed-pmid-9867148-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-9867148-lanreotide:v1","objectPathId":"pubmed-pmid-9867148-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-9867148-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-9867148-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-9867148-lanreotide-v1"},"story":{"slug":"pubmed-pmid-9867148-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 9867148","sourceIds":["pubmed-observation-pmid-9867148-2016-11-24-db844deeb322"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9867148 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9867148-2016-11-24-db844deeb322"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9867148 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9867148-2016-11-24-db844deeb322"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-9867148-2016-11-24-db844deeb322"]}],"sources":[{"id":"pubmed-observation-pmid-9867148-2016-11-24-db844deeb322","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 9867148 · retained source version 1:2016-11-24:current:db844deeb322b4ed3bb246ffb594148350bb1faedfc314af11e640b8d3bf7977","url":"https://pubmed.ncbi.nlm.nih.gov/9867148/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ec9febacffd93c5c6aa30f83497dfa9d67edfbd68bdc49ddd19b82d38b0dd594","tierARecordSha256":"97f11e42df8f94b7d9fa2695816ebb1f623607f4d3d72dd4360418f7f6e59f03"},"integrity":{"algorithm":"sha256","contentSha256":"151d53c713d36060956b33ee55472b23fff65364625d3224e7ad3198ce8017c3"}},"pubmed-pmid-9934776-lanreotide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-9934776-lanreotide:v1","objectPathId":"pubmed-pmid-9934776-lanreotide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-9934776-lanreotide/","json":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.json#pubmed-pmid-9934776-lanreotide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/lanreotide.md#pubmed-pmid-9934776-lanreotide-v1"},"story":{"slug":"pubmed-pmid-9934776-lanreotide","version":1,"domain":"Literature metadata","dateInSource":"2016-11-24","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-12","peptideSlugs":["lanreotide"],"peptides":[{"slug":"lanreotide","url":"https://peptidescanner.com/peptides/lanreotide/"}]},"claims":[{"id":"headline","text":"PubMed record PMID 9934776","sourceIds":["pubmed-observation-pmid-9934776-2016-11-24-70f7210198b9"]},{"id":"summary","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9934776 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-02-06. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9934776-2016-11-24-70f7210198b9"]},{"id":"paragraph-1","text":"PeptideScanner retained PubMed bibliographic metadata for PMID 9934776 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-02-06. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.","sourceIds":["pubmed-observation-pmid-9934776-2016-11-24-70f7210198b9"]},{"id":"paragraph-2","text":"This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-9934776-2016-11-24-70f7210198b9"]}],"sources":[{"id":"pubmed-observation-pmid-9934776-2016-11-24-70f7210198b9","name":"PubMed","sourceClass":"A","title":"PubMed record PMID 9934776 · retained source version 1:2016-11-24:current:70f7210198b9239c9571f33500eeb8979cfc96b1b06d62bbaac6ad00aebcdf08","url":"https://pubmed.ncbi.nlm.nih.gov/9934776/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"46d907a60a578bd50d749748638324f1a319b90e4859605fac72e3e3b4134cf8","tierARecordSha256":"942df50d3b6f13ed1522579b27c643448cd8926eed98847f740cd94464b31a64"},"integrity":{"algorithm":"sha256","contentSha256":"60995943a2e88f805790f3cde2b8a37238be03f7fdb5a78dc0e2b294e83284d6"}}}}
